USRE31006E
(en)
*
|
1968-09-24 |
1982-08-03 |
Akzona Incorporated |
Process for the demonstration and determination of reaction components having specific binding affinity for each other
|
US4203802A
(en)
*
|
1971-05-14 |
1980-05-20 |
Syva Company |
Inhibitable enzyme amplification assay
|
US3875011A
(en)
*
|
1972-11-06 |
1975-04-01 |
Syva Co |
Enzyme immunoassays with glucose-6-phosphate dehydrogenase
|
US3904367A
(en)
*
|
1973-08-15 |
1975-09-09 |
Gen Electric |
Contrast enhancement for immunological film detection
|
US4039652A
(en)
*
|
1973-10-11 |
1977-08-02 |
Miles Laboratories, Inc. |
Column method of immunoassay employing an immobilized binding partner
|
US3951748A
(en)
*
|
1974-11-11 |
1976-04-20 |
Medical Products, Inc. |
Sensitized matrix for detection of disease
|
SE388694B
(sv)
*
|
1975-01-27 |
1976-10-11 |
Kabi Ab |
Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
|
NL7501215A
(nl)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
Methode voor het aantonen en bepalen van een antigeen of antilichaam.
|
IN142734B
(fr)
*
|
1975-04-28 |
1977-08-20 |
Miles Lab |
|
US4016043A
(en)
*
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4642285A
(en)
*
|
1975-09-29 |
1987-02-10 |
Diamedix Corporation |
Sandwich EIA for antigen
|
SE7610683L
(sv)
*
|
1975-09-29 |
1977-06-10 |
Cordis Corp |
Metod for bestemning av nervaron av ett antigen associerat med hepatit
|
US4474878A
(en)
*
|
1975-09-29 |
1984-10-02 |
Cordis Laboratories, Inc. |
Sandwich EIA for antigen associated with hepatitis
|
US4116776A
(en)
*
|
1976-04-19 |
1978-09-26 |
International Radioimmune Systems, Inc. |
Diagnostic blood test and kit for detecting human chorionic gonadotropin
|
GB1572220A
(en)
*
|
1976-10-07 |
1980-07-30 |
Mochida Pharm Co Ltd |
Immunochemical process of measuring physiologically active substances
|
GB1549069A
(en)
*
|
1976-12-10 |
1979-08-01 |
Erba Farmitalia |
Enzyme linked immunoassay
|
JPS5399319A
(en)
*
|
1977-02-09 |
1978-08-30 |
Hidematsu Hirai |
Novel qualitative and quantitative detecting method and detecting body for antgenic substance
|
IT1153999B
(it)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
|
IL51668A
(en)
*
|
1977-03-16 |
1981-12-31 |
Israel State |
Analytical method for the quantitative determination of immunogens and antibodies and a kit therefor
|
CA1108516A
(fr)
*
|
1977-11-21 |
1981-09-08 |
Stanley E. Charm |
Methode pour detecter les traces d'antibiotiques
|
US4275149A
(en)
*
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
NL7804144A
(nl)
*
|
1978-04-18 |
1979-10-22 |
Akzo Nv |
Inrichting voor clorimetrische bepalingen.
|
NZ190452A
(en)
*
|
1978-05-19 |
1981-04-24 |
Becton Dickinson Co |
Solid phase assay receptor contacted with analyte and then with labeled analyte
|
JPS54170918U
(fr)
*
|
1978-05-23 |
1979-12-03 |
|
|
US4273756A
(en)
*
|
1978-07-28 |
1981-06-16 |
Abbott Laboratories |
Immunoassay for class specific antibodies
|
US4292296A
(en)
*
|
1978-09-12 |
1981-09-29 |
Baxter Travenol Laboratories, Inc. |
Diagnostic method
|
US4240751A
(en)
*
|
1978-11-09 |
1980-12-23 |
Akzona Incorporated |
Method and apparatus for specific binding substances
|
US4318707A
(en)
*
|
1978-11-24 |
1982-03-09 |
Syva Company |
Macromolecular fluorescent quencher particle in specific receptor assays
|
US4374925A
(en)
*
|
1978-11-24 |
1983-02-22 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
JPS55116259A
(en)
*
|
1979-03-01 |
1980-09-06 |
Fuji Photo Film Co Ltd |
Microimmunoassay method
|
JPS55116258A
(en)
*
|
1979-03-01 |
1980-09-06 |
Fuji Photo Film Co Ltd |
Microimmunoassay method
|
US4269938A
(en)
*
|
1979-03-08 |
1981-05-26 |
Eastman Kodak Company |
Assay of peroxidatively active materials
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
GB2059421A
(en)
*
|
1979-10-03 |
1981-04-23 |
Self C H |
Assay method and reagents therefor
|
US4446231A
(en)
*
|
1979-10-03 |
1984-05-01 |
Self Colin H |
Immunoassay using an amplified cyclic detection system
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
JPS56143955A
(en)
*
|
1980-04-10 |
1981-11-10 |
Fujirebio Inc |
Method for diagnosis of initial infection of syphilis
|
AU543007B2
(en)
*
|
1980-04-15 |
1985-03-28 |
Technicon Instruments Corportion |
Agglutination immunoassay
|
DE3016575A1
(de)
*
|
1980-04-30 |
1981-11-05 |
Merck Patent Gmbh, 6100 Darmstadt |
Verfahren zur immunologischen bestimmung von enzymen, mittel zur durchfuehrung des verfahrens und seine verwandung
|
EP0111762B1
(fr)
*
|
1980-06-20 |
1987-11-19 |
Unilever Plc |
Procédés et appareil pour l'exécution d'essais de liaisons spécifiques
|
US6406920B1
(en)
|
1980-06-20 |
2002-06-18 |
Inverness Medical Switzerland Gmbh |
Processes and apparatus for carrying out specific binding assays
|
NL185309C
(nl)
|
1980-07-28 |
1990-03-01 |
Akzo Nv |
Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
|
US4376110A
(en)
*
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4486530A
(en)
*
|
1980-08-04 |
1984-12-04 |
Hybritech Incorporated |
Immunometric assays using monoclonal antibodies
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
NZ199286A
(en)
*
|
1980-12-22 |
1986-05-09 |
Commw Serum Lab Commission |
A method of detecting antibodies or an antigenic or haptenic substance in a sample
|
US4517288A
(en)
*
|
1981-01-23 |
1985-05-14 |
American Hospital Supply Corp. |
Solid phase system for ligand assay
|
US4425438A
(en)
*
|
1981-03-13 |
1984-01-10 |
Bauman David S |
Assay method and device
|
GB2095258B
(en)
*
|
1981-03-19 |
1984-09-05 |
Janssen Pharmaceutica Nv |
A bright field light microscopic method of localizing tissue antigens
|
US4592995A
(en)
*
|
1981-03-30 |
1986-06-03 |
Dainippon Pharmaceutical Co., Ltd. |
Reagent for streptococcal anti-esterase assay
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
JPS57193643U
(fr)
*
|
1981-06-03 |
1982-12-08 |
|
|
US4447528A
(en)
*
|
1981-08-10 |
1984-05-08 |
Corning Glass Works |
Detecting intrinsic factor blocking site antibody
|
WO1983000877A1
(fr)
*
|
1981-08-31 |
1983-03-17 |
Icl Scient |
Detection immunohistochimique a l'oxydase de glucose d'anticorps anti-nucleaires
|
US4452886A
(en)
*
|
1981-09-21 |
1984-06-05 |
Henry Robert P |
Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems
|
US4446232A
(en)
*
|
1981-10-13 |
1984-05-01 |
Liotta Lance A |
Enzyme immunoassay with two-zoned device having bound antigens
|
US4753875A
(en)
*
|
1981-11-02 |
1988-06-28 |
Ryan James W |
Method for assaying proteases with tagged proteinaceous inhibitors
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4469787A
(en)
*
|
1982-05-14 |
1984-09-04 |
Mallinckrodt Inc. |
Immunoassay involving soluble complex of second antibody and labeled binding protein
|
US4503143A
(en)
*
|
1982-08-20 |
1985-03-05 |
Btc Diagnostics Limited Partnership |
Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
|
US4530900A
(en)
*
|
1982-09-13 |
1985-07-23 |
Seragen Diagnostics Inc. |
Soluble insoluble polymers in enzymeimmunoassay
|
FR2550799B1
(fr)
*
|
1983-08-17 |
1986-02-21 |
Commissariat Energie Atomique |
Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
|
JPS60501570A
(ja)
*
|
1983-11-08 |
1985-09-19 |
クイデル |
迅速プランジヤ−免疫学的検定法及び装置
|
US4777240A
(en)
*
|
1984-03-08 |
1988-10-11 |
Scripps Clinic And Research Foundation |
SV40 expression vector containing HBxAg as an expression marker
|
US4645828A
(en)
|
1984-03-23 |
1987-02-24 |
Oncogen |
Platelet related growth regulator
|
US4665020A
(en)
*
|
1984-05-30 |
1987-05-12 |
United States Department Of Energy |
Flow cytometer measurement of binding assays
|
US4812395A
(en)
*
|
1984-11-05 |
1989-03-14 |
E. I. Du Pont De Nemours And Company |
Method for detecting enzymatic activity using particle agglutination
|
US4812396A
(en)
*
|
1984-11-05 |
1989-03-14 |
E. I. Du Pont De Nemours And Company |
Method for detecting enzymatic activity using particle agglutination
|
US4713347A
(en)
*
|
1985-01-14 |
1987-12-15 |
Sensor Diagnostics, Inc. |
Measurement of ligand/anti-ligand interactions using bulk conductance
|
US4824784A
(en)
*
|
1985-04-08 |
1989-04-25 |
Hygeia Sciences, Incorporated |
Chromogenic solution for immunoassay
|
US4837395A
(en)
*
|
1985-05-10 |
1989-06-06 |
Syntex (U.S.A.) Inc. |
Single step heterogeneous assay
|
US4931385A
(en)
*
|
1985-06-24 |
1990-06-05 |
Hygeia Sciences, Incorporated |
Enzyme immunoassays and immunologic reagents
|
US4868108A
(en)
*
|
1985-12-12 |
1989-09-19 |
Hygeia Sciences, Incorporated |
Multiple-antibody detection of antigen
|
CH670709A5
(fr)
*
|
1986-04-24 |
1989-06-30 |
Univ Moskovsk |
|
US5334513A
(en)
*
|
1988-05-17 |
1994-08-02 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5039607A
(en)
*
|
1988-05-17 |
1991-08-13 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5102788A
(en)
*
|
1988-11-21 |
1992-04-07 |
Hygeia Sciences, Inc. |
Immunoassay including lyophilized reactant mixture
|
US5135863A
(en)
*
|
1988-12-23 |
1992-08-04 |
Syntex (U.S.A.) Inc. |
Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
WO1992020820A1
(fr)
*
|
1991-05-15 |
1992-11-26 |
Vanderbilt University |
Methode de determination du potentiel metastatique des cellules tumorales
|
US5348867A
(en)
*
|
1991-11-15 |
1994-09-20 |
George Georgiou |
Expression of proteins on bacterial surface
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US5869445A
(en)
*
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
US6953573B1
(en)
|
1993-03-17 |
2005-10-11 |
University Of Washington |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
US5801005A
(en)
*
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
AU679008B2
(en)
*
|
1993-05-06 |
1997-06-19 |
Chiron Diagnostics Corporation |
Mixed luminescent conjugate test assays
|
AU2635295A
(en)
*
|
1994-06-13 |
1996-01-05 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US5698686A
(en)
|
1994-10-20 |
1997-12-16 |
Arch Development Corporation |
Yeast telomerase compositions
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5858661A
(en)
*
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5807552A
(en)
*
|
1995-08-04 |
1998-09-15 |
Board Of Regents, The University Of Texas System |
Compositions for conferring immunogenicity to a substance and uses thereof
|
US6689757B1
(en)
|
1996-02-12 |
2004-02-10 |
M.L. Laboratories Plc |
Methods for vaccination and vaccines therefor
|
US6942862B2
(en)
*
|
1996-04-01 |
2005-09-13 |
University Of Washington |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
US20050214827A1
(en)
*
|
1996-07-08 |
2005-09-29 |
Burstein Technologies, Inc. |
Assay device and method
|
JP2002514046A
(ja)
|
1996-07-08 |
2002-05-14 |
バースタイン テクノロジーズ,インコーポレイティド |
切断可能なシグナル因子の装置および方法
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
EP1015471A1
(fr)
*
|
1997-08-21 |
2000-07-05 |
Quark Biotech, Inc. |
Genes regules au niveau de l'hypoxemie
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
EP1027453A4
(fr)
|
1997-10-17 |
2004-12-01 |
Univ South Florida |
Procede de diagnostic et de surveillance des deficiences immunitaires cellulaires
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
US7605149B1
(en)
|
1998-07-13 |
2009-10-20 |
University Of South Florida |
Modulation of the phospholipase A2 pathway as a therapeutic
|
CA2338401A1
(fr)
*
|
1998-07-21 |
2000-02-03 |
Burstein Laboratories, Inc |
Dispositifs de dosage utilisant des disques optiques et methodes correspondantes
|
CA2303855A1
(fr)
|
1998-07-22 |
2000-02-03 |
Jin Po Lee |
Dispositif permettant de deceler differents composants
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
IL142094A0
(en)
*
|
1998-09-29 |
2002-03-10 |
Gamida Cell Ltd |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
US6656471B1
(en)
|
1998-11-17 |
2003-12-02 |
Board Of Regents, The University Of Texas System |
HIV-specific T-cell induction
|
NZ513303A
(en)
*
|
1999-02-04 |
2003-03-28 |
Technion Res & Dev Foundation |
Three dimensional plug flow bioreactor, and its use for the maintenance and expansion of hemopoietic stem cells and/or progenitor cells
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
CA2377541A1
(fr)
*
|
1999-06-25 |
2001-01-04 |
Eduardo N. Mitrani |
Procede permettant d'induire une angiogenese au moyen de micro-organes
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7811981B2
(en)
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US7167615B1
(en)
|
1999-11-05 |
2007-01-23 |
Board Of Regents, The University Of Texas System |
Resonant waveguide-grating filters and sensors and methods for making and using same
|
NZ519043A
(en)
*
|
1999-11-19 |
2006-12-22 |
Yissum Res Dev Co |
Nucleic acid comprising a gene derived from Aspergillus niger that encodes a polypeptide that has a beta-glucosidase catalytic activity
|
US6544506B2
(en)
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
WO2001053323A2
(fr)
*
|
2000-01-24 |
2001-07-26 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Plantes tolerant le stress de l'environnement, procedes d'elaboration pour ce type de plante et sequence polynucleotidique utilisee a cet effet
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
AU785493B2
(en)
|
2000-03-27 |
2008-01-03 |
Technion Research & Development Foundation Ltd. |
Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
ES2437093T3
(es)
|
2000-08-08 |
2014-01-08 |
Technion Research And Development Foundation, Ltd. |
Composiciones farmacéuticas y procedimientos útiles para modular la angiogénesis
|
EP1683874A3
(fr)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Méthode pour l'isolement de gènes codant pour des protéines à fonction spécifique et pour le criblage d'agents pharmaceutiques actifs
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
EP1379127B1
(fr)
*
|
2000-09-28 |
2013-04-17 |
Nanocyte Inc. |
Procedes, compositions et dispositifs utilisant des cellules/capsules urticantes pour administrer un agent therapeutique ou cosmetique dans un tissu
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
AU2002211201B2
(en)
*
|
2000-11-02 |
2007-05-31 |
The National University Of Singapore |
aopB Gene, protein, homologs, fragments and variants thereof, and their use for cell surface display
|
EP2386319B1
(fr)
|
2000-11-17 |
2013-06-05 |
Vascular Biogenics Ltd. |
Promoteurs présentant une specificité pour des cellules endotheliales et leurs procédés d'utilisation
|
US7585666B2
(en)
|
2001-10-19 |
2009-09-08 |
Vascular Biogenics Ltd. |
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
AU2002218461B2
(en)
|
2000-11-24 |
2006-09-07 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
US20020172980A1
(en)
*
|
2000-11-27 |
2002-11-21 |
Phan Brigitte Chau |
Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
|
US20040248093A1
(en)
*
|
2000-11-27 |
2004-12-09 |
Coombs James Howard |
Magneto-optical bio-discs and systems including related methods
|
US20030003464A1
(en)
*
|
2000-11-27 |
2003-01-02 |
Phan Brigitte C. |
Dual bead assays including optical biodiscs and methods relating thereto
|
AU2085502A
(en)
|
2000-11-30 |
2002-06-11 |
Molecular Skincare Ltd |
Diagnosis and treatment of disease
|
IL155941A0
(en)
*
|
2000-11-30 |
2003-12-23 |
Yeda Res & Dev |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
US20020142287A1
(en)
*
|
2000-12-14 |
2002-10-03 |
Hirotaka Yamamoto |
High throughput assay to detect inhibitors of the map kinase pathway
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
AU2002230061A1
(en)
*
|
2001-01-31 |
2002-08-12 |
Tolaren |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20050202098A1
(en)
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
EP1493014A2
(fr)
|
2001-04-11 |
2005-01-05 |
Burstein Technologies, Inc. |
Dosages a parametres multiples mettant en oeuvre des disques d'analyse, et procedes s'y rapportant
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
MXPA04000397A
(es)
*
|
2001-07-19 |
2004-03-18 |
Yissum Res Dev Co |
Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
|
CA2458640A1
(fr)
|
2001-08-16 |
2003-03-06 |
Bar-Ilan University |
Diagnostic, prevention et traitement du cancer
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
AUPR842501A0
(en)
*
|
2001-10-23 |
2001-11-15 |
Epipop Pty Ltd |
A method for identification and development of therapeutic agents
|
US6867005B2
(en)
|
2001-10-24 |
2005-03-15 |
Beckman Coulter, Inc. |
Method and apparatus for increasing the dynamic range and accuracy of binding assays
|
US6696254B2
(en)
|
2001-11-21 |
2004-02-24 |
Kimberly-Clark Worldwide, Inc. |
Detection and identification of enteric bacteria
|
WO2003048298A2
(fr)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticules contenant des homologues d'acides nucleiques polymeres, compositions pharmaceutiques et articles fabriques contenant ces nanoparticules, et procedes d'utilisation de celles-ci
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(fr)
*
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methodes de developpement de cellules souches et de cellules precurseurs, populations de cellules multipliees obtenues a l'aide de ces methodes
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US6992176B2
(en)
*
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
CA2476625A1
(fr)
*
|
2002-02-20 |
2003-08-28 |
Dyax Corp. |
Ligands de liaison au complexe mhc-peptide
|
SI1487972T1
(sl)
|
2002-02-21 |
2016-03-31 |
Institute Of Virology Slovak Academy Of Sciences |
Monoklonska protitelesa, specifična za MN/CA IX, proizvedena iz MN/CA IX deficientnih miši, in postopki uporabe
|
JP2005520511A
(ja)
*
|
2002-03-18 |
2005-07-14 |
ガミダ セル リミテッド |
エクスビボ拡大培養された幹細胞における分化を誘導する方法
|
EP1519755B1
(fr)
*
|
2002-03-26 |
2008-05-07 |
Nanocyte Inc. |
Cellules urticantes exprimant un polynucleotide exogene qui code pour un agent therapeutique, diagnostic ou cosmetique, et procedes, compositions et dispositifs faisant intervenir l'utilisation de ces cellules urticantes ou de capsules derivees de celles-ci pour administrer l'agent therapeutique, di
|
ATE437235T1
(de)
*
|
2002-04-16 |
2009-08-15 |
Univ California |
Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
AU2003242967A1
(en)
*
|
2002-07-12 |
2004-02-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method and device for inducing biological processes by micro-organs
|
AU2003247143B2
(en)
|
2002-08-01 |
2009-07-16 |
Yeda Research And Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
AU2003265523A1
(en)
|
2002-08-20 |
2004-03-11 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
WO2004037204A2
(fr)
*
|
2002-10-25 |
2004-05-06 |
University Of South Florida |
Methodes et composes de perturbation de la signalisation cd40r/cd40l dans le traitement de la maladie d'alzheimer
|
EP2295980A1
(fr)
|
2002-10-30 |
2011-03-16 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Molécules et leurs procédés d'utilisation pour la mesure de fer non lié par la transferrine
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
US7947499B2
(en)
*
|
2002-11-29 |
2011-05-24 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
AU2003286410A1
(en)
|
2002-12-12 |
2004-06-30 |
R.B.T (Rakuto Bio Technologies) Ltd. |
Methods of producing lignin peroxidase and its use in skin and hair lightening
|
AU2003303071B2
(en)
|
2002-12-16 |
2009-04-23 |
Technion Research & Development Foundation Ltd. |
Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
|
US7847084B2
(en)
|
2002-12-20 |
2010-12-07 |
Board Of Regents, The University Of Texas System |
VMP-like sequences of pathogenic Borrelia species and strains
|
CA2512499A1
(fr)
|
2003-01-02 |
2004-07-22 |
Rappaport Family Institute For Research In The Medical Sciences |
Methodes de prediction de potentiel a tirer benefice d'un traitement antioxydant pour la prevention de maladies cardiovasculaires chez des patients hyperglycemiques
|
DE602004020179D1
(de)
*
|
2003-01-07 |
2009-05-07 |
Univ Ramot |
Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
|
US20050032126A1
(en)
*
|
2003-03-03 |
2005-02-10 |
Coombs James H. |
Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
|
US7786071B2
(en)
|
2003-03-04 |
2010-08-31 |
Yeda Research And Development Co. Ltd. |
Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same
|
US20050054103A1
(en)
*
|
2003-03-07 |
2005-03-10 |
Tony Peled |
Expansion of renewable stem cell populations using modulators of PI 3-kinase
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
US7524938B2
(en)
|
2003-04-04 |
2009-04-28 |
Yeda Research And Development Co., Ltd. |
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
|
AU2004227204B2
(en)
|
2003-04-08 |
2010-06-03 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
WO2005035556A2
(fr)
*
|
2003-05-06 |
2005-04-21 |
Iguazu Biosciences Corp. |
Particules pseudo-virales du coronavirus du sras et methodes d'utilisation
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
EP2365087A3
(fr)
|
2003-05-22 |
2011-11-30 |
Evogene Ltd. |
Procédés d'augmentation de la tolérance du stress abiotique des plantes et plantes ainsi produites
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
WO2005032455A2
(fr)
|
2003-05-23 |
2005-04-14 |
Board Of Regents |
Oligonucleoside phosphorothioate selectionnes de maniere combinatoire et a base structurelle et facteurs de transcription ap-1 ciblant un phosphorodithioate aptamere
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US7498428B2
(en)
*
|
2003-06-19 |
2009-03-03 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
KR101215821B1
(ko)
|
2003-06-30 |
2012-12-28 |
텔 아비브 유니버시티 퓨쳐 테크놀로지 디벨롭먼트 엘.피. |
아밀로이드 관련 질환을 진단 및 처치하기 위한 펩타이드, 그것에 대한 항체, 및 그 사용방법
|
AU2004257645A1
(en)
*
|
2003-07-07 |
2005-01-27 |
David H. Wagner |
Methods for predicting development of auto-immune diseases and treatment of same
|
JP2007518394A
(ja)
*
|
2003-08-14 |
2007-07-12 |
ザ バイオ バランス コーポレイション |
細菌菌株、該細菌菌株を含む組成物、およびそのプロバイオティクス使用
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
DK1678209T3
(da)
|
2003-10-07 |
2011-06-27 |
Yeda Res & Dev |
Antistoffer mod nik, deres frembringelse samt anvendelse
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
CA2542221A1
(fr)
*
|
2003-10-23 |
2005-05-06 |
Pfizer Products Inc. |
Vaccin contre les parodontopathies
|
CA2544951A1
(fr)
|
2003-11-04 |
2005-05-19 |
Chiron Corporation |
Utilisation d'anticorps monoclonaux antagonistes anti-cd40 pour le traitement de myelome multiple
|
EP1682178B8
(fr)
|
2003-11-04 |
2010-09-01 |
Novartis Vaccines and Diagnostics, Inc. |
Procedes de therapie pour des cancers exprimant l'antigene cd40
|
EP1682177B8
(fr)
|
2003-11-04 |
2010-09-01 |
Novartis Vaccines and Diagnostics, Inc. |
Utilisation d'anticorps anti-cd40 antagonistes pour le traitement de la leucemie lymphocytique chronique
|
CA2544852A1
(fr)
|
2003-11-04 |
2005-05-19 |
Chiron Corporation |
Procedes therapeutiques de tumeurs solides exprimant l'antigene de surface cellulaire cd40
|
CA2547459C
(fr)
|
2003-11-30 |
2013-10-08 |
Yeda Research And Development Co. Ltd |
Procedes et agents pour mettre en oeuvre une modulation immunitaire et procedes d'identification de modulateurs immunitaires
|
WO2005059100A2
(fr)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Procedes et compositions se rapportant a la cystatine c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
EP2289567A3
(fr)
|
2003-12-22 |
2011-06-22 |
Regentis Biomaterials Ltd. |
Matrice à base de protéines naturelles réticulées
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
US20060147946A1
(en)
*
|
2004-01-27 |
2006-07-06 |
Pinchas Akiva |
Novel calcium channel variants and methods of use thereof
|
US7456149B2
(en)
|
2004-03-02 |
2008-11-25 |
Acceleron Pharma, Inc. |
ALK7 and myostatin inhibitors and uses thereof
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
US7812218B2
(en)
*
|
2004-06-14 |
2010-10-12 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2006006172A2
(fr)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Utilisation d'agents anti-amyloides pour traiter et determiner des infections pathogenes
|
EP2295974A1
(fr)
*
|
2004-09-08 |
2011-03-16 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Compositions et procédés pour la détection d'une infection par VIH-1/VIH-2
|
EP1799812A4
(fr)
*
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
Méthodes de culture ex vivo de cellules souches et de précurseur par co-culture avec des cellules mésenchymales
|
US8000900B2
(en)
|
2004-09-21 |
2011-08-16 |
Microsoft Corporation |
Association-based predictions of pathogen characteristics
|
US20060095241A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
EP2357241B1
(fr)
|
2004-09-29 |
2015-03-04 |
Collplant Ltd. |
Collagène recombinant produit dans une plante
|
BRPI0516302A
(pt)
*
|
2004-09-29 |
2008-09-02 |
Yissun Res Dev Company Of The |
rnase t2 humana recombinante e suas utilizações
|
WO2006040765A1
(fr)
*
|
2004-10-12 |
2006-04-20 |
Closed Loop Therapies Ltd. |
Methodes et dispositifs implantables pour traiter des arythmies supraventriculaires
|
US8478535B2
(en)
|
2004-10-29 |
2013-07-02 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
WO2006048262A2
(fr)
*
|
2004-11-04 |
2006-05-11 |
Roche Diagnostics Gmbh |
Classification de la leucemie myeloblastique aigue
|
US7842794B2
(en)
|
2004-12-17 |
2010-11-30 |
Roche Molecular Systems, Inc. |
Reagents and methods for detecting Neisseria gonorrhoeae
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
US20080082678A1
(en)
*
|
2005-01-16 |
2008-04-03 |
Zlango Ltd. |
Communications Network System and Methods for Using Same
|
EP1844403A4
(fr)
*
|
2005-01-16 |
2010-06-23 |
Zlango Ltd |
Communication iconique
|
EP1843850B1
(fr)
|
2005-01-31 |
2015-11-18 |
Realbio Technologies Ltd. |
Dispositif capillaire a flux lateral de reaction par etapes multiples
|
US8257742B2
(en)
|
2005-02-17 |
2012-09-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Bisphosphonates for treating endometriosis
|
US8216801B2
(en)
|
2005-02-25 |
2012-07-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center |
Methods for treating inflammatory disorders
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
US20090068207A1
(en)
*
|
2005-04-15 |
2009-03-12 |
Vascular Biogenics Ltd. |
Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
PT1889065E
(pt)
|
2005-05-18 |
2013-09-27 |
Novartis Ag |
Métodos para o diagnóstico e tratamento de doenças tendo uma componente autoimune e/ou inflamatória
|
EP1888034A2
(fr)
|
2005-05-26 |
2008-02-20 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Compositions et methodes d'utilisation desdites compositions dans l'administration d'agents dans un organe cible protege par une barriere sanguine
|
ES2524996T3
(es)
|
2005-06-16 |
2014-12-16 |
Ramot At Tel Aviv University Ltd. |
Células aisladas y poblaciones que comprenden a las mismas para el tratamiento de enfermedades del SNC
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
US20060292559A1
(en)
*
|
2005-06-23 |
2006-12-28 |
Beckman Coulter, Inc. |
Cell-based microarrays, and methods for their preparation and use
|
US9051379B2
(en)
|
2005-07-07 |
2015-06-09 |
Fulcrum Sp Ltd. |
Sp1 polypeptides, modified Sp1 polypeptides and uses thereof
|
AU2006267841B2
(en)
*
|
2005-07-07 |
2011-12-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid agents for downregulating H19, and methods of using same
|
EP2441840B1
(fr)
|
2005-07-18 |
2017-09-06 |
Protalix Ltd. |
Administration mucosale ou enterale de macromolecules biologiquement actives
|
CA2616766A1
(fr)
|
2005-07-26 |
2007-02-01 |
University Of Medicine And Dentistry Of New Jersey |
Profils d'anticorps specifiques d'un etat tuberculeux
|
US8642330B2
(en)
*
|
2005-08-08 |
2014-02-04 |
Onconon, Llc |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
US8916147B2
(en)
|
2005-08-24 |
2014-12-23 |
Yeda Research and Devolpment Co. Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
WO2007026353A2
(fr)
|
2005-08-29 |
2007-03-08 |
Technion Research & Development Foundation Ltd. |
Milieux de culture de cellules souches
|
WO2007034487A1
(fr)
|
2005-09-22 |
2007-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Constructions d’acide nucléique, compositions pharmaceutiques et procédés utilisant ces dernières dans le cadre des traitements anticancéreux
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
MX350551B
(es)
|
2005-10-24 |
2017-09-08 |
Evogene Ltd |
Polipeptidos aislados, polinucleotidos que los codifican, plantas transgenicas que expresan los mismos y metodos para usarlos.
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
ES2409128T3
(es)
|
2005-11-29 |
2013-06-25 |
Gamida Cell Ltd. |
Procedimientos de mejora de anidamiento e injerto de células madre
|
EP1982450A2
(fr)
*
|
2006-01-16 |
2008-10-22 |
Zlango Ltd. |
Systeme de reseau de communication et ses procedes d'utilisation
|
WO2007080559A2
(fr)
|
2006-01-16 |
2007-07-19 |
Zlango Ltd. |
Communication iconique
|
CA2637598A1
(fr)
|
2006-01-18 |
2007-02-14 |
University Of Chicago |
Compositions et procedes se rapportant a des proteines de bacteries staphylococciques
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
WO2007092252A2
(fr)
|
2006-02-03 |
2007-08-16 |
Modigene Inc |
Polypeptides a action prolongee et leurs procedes de production
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
JP2009526219A
(ja)
|
2006-02-06 |
2009-07-16 |
ラパポート ファミリー インスティテュート フォー リサーチ イン ザ メディカル サイエンシーズ |
T1dmを診断するための方法及びキット
|
EP1991852B1
(fr)
|
2006-03-06 |
2015-07-01 |
Zetiq Technologies Ltd. |
Procédés pour identifier un phénotype cellulaire
|
SG170761A1
(en)
|
2006-03-23 |
2011-05-30 |
Pluristem Ltd |
Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
|
WO2007110869A2
(fr)
|
2006-03-28 |
2007-10-04 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procedes et kits pour determiner la predisposition a la resistance a la warfarine
|
MX2008012754A
(es)
*
|
2006-04-07 |
2009-04-27 |
Us Gov Health & Human Serv |
Composiciones de anticuerpos y metodos para tratamiento de enfermedad neoplastica.
|
SMP200800064B
(it)
|
2006-04-21 |
2009-11-06 |
Novartis Ag |
Composizioni farmaceutiche di anticorpi anti-cd40 antagonista
|
JP5225266B2
(ja)
*
|
2006-05-19 |
2013-07-03 |
テバ ファーマシューティカル インダストリーズ リミティド |
融合タンパク質、その使用、およびその製造方法
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
US8629259B2
(en)
|
2006-07-20 |
2014-01-14 |
Yeda Research And Development Co. Ltd. |
Photosynthetic organisms and compositions and methods of generating same
|
EP2064319B1
(fr)
|
2006-08-28 |
2017-02-22 |
Yeda Research and Development Co. Ltd. |
Méthodes de production de cellules gliales et neuronales et leur utilisation pour le traitement de troubles médicaux du système nerveux central
|
CA2662323A1
(fr)
*
|
2006-09-08 |
2008-03-13 |
Wisconsin Alumni Research Foundation |
Analyse pour les anticorps envers le bacille de koch
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
US20100129656A1
(en)
|
2006-10-05 |
2010-05-27 |
Technion Research & Develpment Foundation Ltd |
Microtubes and methods of producing same
|
MX2009006660A
(es)
|
2006-12-20 |
2009-08-20 |
Evogene Ltd |
Polinucleotidos y polipeptidos involucrados en el desarrollo de fibra vegetal y metodos de uso.
|
GB0700133D0
(en)
|
2007-01-04 |
2007-02-14 |
Humabs Llc |
Human cytomegalovirus neutralising antibodies and use thereof
|
ATE548454T1
(de)
*
|
2007-01-16 |
2012-03-15 |
Yissum Res Dev Co |
Nukleinsäurewirkstoffe zur stilllegung von h19 zwecks behandlung rheumatoider arthritis
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
EP2117616A2
(fr)
|
2007-01-31 |
2009-11-18 |
Technion Research & Development Foundation Ltd. |
Échafaudages électrofilés et leurs procédés de génération et d'utilisation
|
CA2676932C
(fr)
|
2007-02-01 |
2015-11-24 |
Technion Research & Development Foundation Ltd. |
Fibres et tissus d'albumine et leurs procedes de generation et d'utilisation
|
NZ578657A
(en)
*
|
2007-02-02 |
2012-02-24 |
Baylor Res Inst |
Multivariable antigens complexed with targeting humanized monoclonal antibody
|
TWI422594B
(zh)
|
2007-02-02 |
2014-01-11 |
Baylor Res Inst |
經由樹狀細胞去唾液酸糖蛋白受體(dc-asgpr)接合抗原呈現細胞之藥劑
|
JP5377330B2
(ja)
|
2007-02-02 |
2013-12-25 |
ベイラー リサーチ インスティテュート |
抗原提示細胞上に発現されたdcirへの抗原のターゲティングに基づくワクチン
|
NZ624059A
(en)
*
|
2007-02-23 |
2015-10-30 |
Baylor Res Inst |
Therapeutic applications of activation of human antigen-presenting cells through dectin-1
|
CN101668777A
(zh)
*
|
2007-02-23 |
2010-03-10 |
贝勒研究院 |
通过clec-6激活人抗原呈递细胞
|
CN101668772A
(zh)
|
2007-02-23 |
2010-03-10 |
贝勒研究院 |
通过树突细胞凝集素样氧化型ldl受体-1(lox-1)激活人抗原呈递细胞
|
EP2839839B1
(fr)
|
2007-02-28 |
2018-01-17 |
Yeda Research And Development Company Limited |
Sequences de ciblage du noyau
|
EP2144935A2
(fr)
|
2007-03-29 |
2010-01-20 |
Technion Research & Development Foundation Ltd. |
Anticorps, procédés et kits de diagnostic et de traitement de mélanomes
|
EP2142661B1
(fr)
|
2007-04-02 |
2012-08-29 |
Ramot at Tel-Aviv University Ltd. |
Procédés permettant de détecter des cellules cancéreuses et leur utilisation pour diagnostiquer et surveiller le traitement de la maladie
|
MX341624B
(es)
|
2007-04-09 |
2016-08-26 |
Evogene Ltd |
Polinucleotidos, polipeptidos y metodos para aumentar el contenido de aceite, la velocidad de crecimiento y biomasa de las plantas.
|
WO2008129548A2
(fr)
*
|
2007-04-23 |
2008-10-30 |
Segev Laboratories Limited |
Système pour administrer des agents thérapeutiques dans des cellules vivantes et noyaux de cellules
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
EP2152905B1
(fr)
|
2007-05-01 |
2015-12-02 |
Tel Hashomer Medical Research Infrastructure and Services Ltd. |
Procédés et trousses de détection de cellules f tales dans le sang maternel
|
AU2008246368A1
(en)
|
2007-05-03 |
2008-11-13 |
Agency For Science, Technology And Research |
Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide
|
ES2660667T3
(es)
|
2007-05-07 |
2018-03-23 |
Protalix Ltd. |
Biorreactor desechable a gran escala
|
EP2176409B1
(fr)
|
2007-07-11 |
2012-01-04 |
Yeda Research And Development Co. Ltd. |
Systèmes de produits de construction d'acide nucléique pouvant diagnostiquer ou traiter un état cellulaire
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
WO2009010968A2
(fr)
|
2007-07-15 |
2009-01-22 |
Yitzchak Hillman |
Traitement de maladie par des peptides antimicrobien ou leurs inhibiteurs
|
ES2547305T3
(es)
|
2007-07-24 |
2015-10-05 |
Evogene Ltd. |
Polinucleótidos, polipéptidos codificados por los mismos, y métodos de uso de los mismos para aumentar la tolerancia al estrés abiótico y/o la biomasa y/o el rendimiento en plantas que los expresan
|
SI2182981T1
(sl)
*
|
2007-08-02 |
2013-05-31 |
Gilead Biologics, Inc. |
Postopki in sestavki za zdravljenje in diagnozo fibroze
|
EP2185175B1
(fr)
|
2007-08-15 |
2013-02-13 |
Yeda Research and Development Co. Ltd. |
Régulateurs de la mmp-9 et leurs utilisations
|
EP2195650B1
(fr)
|
2007-09-12 |
2016-07-06 |
Yeda Research And Development Company Ltd. |
Procédés de traitement de tumeurs dans des sites privilégiés immunitairement
|
US20090068669A1
(en)
*
|
2007-09-12 |
2009-03-12 |
Elias Georges |
Slc9a3r1 directed diagnostics for neoplastic disease
|
US8529888B2
(en)
|
2007-09-19 |
2013-09-10 |
Pluristem Ltd. |
Adherent cells from adipose or placenta tissues and use thereof in therapy
|
ES2505440T3
(es)
|
2007-10-19 |
2014-10-09 |
Rappaport Family Institute For Research In The Medical Sciences |
Composiciones que comprenden semaforinas para el tratamiento de las enfermedades relacionadas con la angiogénesis y los procedimientos de selección de las mismas
|
US9138470B2
(en)
*
|
2007-11-02 |
2015-09-22 |
The Johns Hopkins University |
Multi-component L2 vaccine for prevention of human papilloma virus infection
|
EP2599790A1
(fr)
|
2007-11-26 |
2013-06-05 |
Yissum Research Development Company of The Hebrew University of Jerusalem |
Compositions comprenant des polypeptides fibreux et des polysachharides
|
CA2709517C
(fr)
|
2007-12-27 |
2019-02-26 |
Evogene Ltd. |
Polypeptides isoles, polynucleotides utiles pour modifier l'efficacite de l'utilisation de l'eau, l'efficacite de l'utilisation de fertilisant, la tolerance au stress biotique/abiotique, le rendement et la biomasse chez les plantes
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
WO2009095925A2
(fr)
*
|
2008-01-31 |
2009-08-06 |
Compugen Ltd. |
Polypeptides et polynucléotides et leurs utilisations en tant que cible médicamenteuse pour produire des médicaments et des produits biologiques
|
ES2483465T3
(es)
|
2008-02-21 |
2014-08-06 |
Technion Research And Development Foundation, Ltd. |
Uso de microtubos de electro-hilado para suministrar un fármaco
|
WO2009117462A1
(fr)
*
|
2008-03-18 |
2009-09-24 |
Wisconsin Alumini Research Foundation |
Test de criblage de culture mycobactérienne pour une bactérie complexe de mycobacterium avium
|
EP2297200A1
(fr)
*
|
2008-04-09 |
2011-03-23 |
Technion Research & Development Foundation Ltd. |
Anticorps antigrippe et leurs utilisations
|
US8747855B2
(en)
*
|
2008-04-09 |
2014-06-10 |
Technion Research & Development Foundation Limited |
Anti human immunodeficiency antibodies and uses thereof
|
CN102083615B
(zh)
*
|
2008-04-10 |
2014-08-13 |
战略系统有限公司 |
用于三维模型打印的系统和方法
|
CN104491845A
(zh)
|
2008-04-18 |
2015-04-08 |
科尔普兰特有限公司 |
产生和使用原胶原的方法
|
EP2936976A1
(fr)
|
2008-04-21 |
2015-10-28 |
Danziger Innovations Ltd. |
Vecteurs d'expression de virus de plante et leur utilisation pour générer des variations génotypiques dans des génomes de plantes
|
SG157299A1
(en)
|
2008-05-09 |
2009-12-29 |
Agency Science Tech & Res |
Diagnosis and treatment of kawasaki disease
|
AU2009250806B2
(en)
*
|
2008-05-22 |
2015-04-16 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility
|
AU2009252722A1
(en)
|
2008-05-27 |
2009-12-03 |
Pluristem Ltd. |
Methods of treating inflammatory colon diseases
|
US8663987B2
(en)
|
2008-05-28 |
2014-03-04 |
Ramot At Tel-Aviv University Ltd. |
Mesenchymal stem cells for the treatment of CNS diseases
|
US9952211B2
(en)
|
2008-06-29 |
2018-04-24 |
Realbio Technologies Ltd. |
Liquid-transfer device particularly useful as a capturing device in a biological assay process
|
NZ594540A
(en)
|
2008-07-16 |
2012-01-12 |
Baylor Res Inst |
Hiv vaccine based on targeting maximized gag and nef antigen to dendritic cells using antibodies
|
CN106924729B
(zh)
|
2008-07-16 |
2021-03-02 |
生物医学研究学会 |
人巨细胞病毒中和抗体及其应用
|
AU2008359583B2
(en)
|
2008-07-16 |
2012-04-05 |
Institute For Research In Biomedicine |
Human cytomegalovirus neutralising antibodies and use thereof
|
BRPI0911699B8
(pt)
*
|
2008-07-25 |
2023-02-28 |
Inst Res Biomedicine |
vetor, célula, composição farmacêutica, uso de um anticorpo, ou fragmento de ligação a antígeno deste
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
US20120122800A1
(en)
|
2008-08-08 |
2012-05-17 |
Genisphere, LLC Hatfield, Pennsylvania |
Long-Acting DNA Dendrimers and Methods Thereof
|
EP2331107A4
(fr)
|
2008-08-08 |
2011-08-24 |
Agency Science Tech & Res |
Vhz pour le diagnostic et le traitement de cancers
|
US9018445B2
(en)
*
|
2008-08-18 |
2015-04-28 |
Evogene Ltd. |
Use of CAD genes to increase nitrogen use efficiency and low nitrogen tolerance to a plant
|
BRPI0913452A2
(pt)
|
2008-09-02 |
2015-12-01 |
Pluristem Ltd |
células aderentes provenientes do tecido placentário e seu uso em terapia
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
US20110305682A1
(en)
|
2008-09-11 |
2011-12-15 |
Ben Gurion University Of The Negev Research And Development Authority |
Compositions and Methods for Treating S. Pneumonia Infection
|
CN107595889A
(zh)
|
2008-09-12 |
2018-01-19 |
克里奥普拉斯低温生物有限公司 |
缺血性组织的细胞疗法
|
SG10202000552YA
(en)
|
2008-09-24 |
2020-03-30 |
Tel Hashomer Medical Research Infrastructure And Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
US20110178024A1
(en)
|
2008-09-29 |
2011-07-21 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
CN102333540B
(zh)
|
2008-10-06 |
2015-04-22 |
芝加哥大学 |
与细菌eap、emp和/或adsa蛋白相关的组合物和方法
|
BRPI0914522B1
(pt)
|
2008-10-30 |
2019-04-02 |
Evogene Ltd |
Método para aumentar o rendimento, a biomassa, a taxa de crescimento, o vigor, oteor de óleo, e/ou a eficiência da utilização do nitrogênio de uma planta
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(fr)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps anti-cd44vra et procédés diagnostiques et thérapeutiques l'utilisant
|
WO2010061383A1
(fr)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
Procédé permettant d’enrichir in-situ des aliments avec des fructanes
|
WO2010064231A1
(fr)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés d’analyse d’édition d’arn a-i et constructions d’acide nucléique capables de ceux-ci
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
WO2010064248A2
(fr)
|
2008-12-05 |
2010-06-10 |
Yeda Research And Development Co. Ltd. |
Procédés de diagnostic et de traitement des maladies des motoneurones
|
WO2010071610A1
(fr)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Marqueurs biologiques de chikungunya sévère
|
KR101383408B1
(ko)
|
2008-12-29 |
2014-04-17 |
텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드. |
세포 유착 방지를 위한 펩티드와 조성물 및 그것의 사용 방법
|
WO2010076788A2
(fr)
|
2008-12-29 |
2010-07-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de la réponse au traitement par un interféron et traitement d'une infection par l'hépatite c
|
CA3052515A1
(fr)
|
2008-12-29 |
2010-07-08 |
Evogene Ltd. |
Polynucleotides, polypeptides codes par ceux-ci, et leurs procedes d'utilisation pour augmenter la tolerance au stress abiotique, la biomasse et/ou le rendement dans les plantes les exprimant
|
US8455263B2
(en)
|
2008-12-30 |
2013-06-04 |
Jin Po Lee |
Quantitative analyte assay device and method
|
WO2010076794A1
(fr)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Procédé pour dénitrifier une saumure et systèmes aptes à une telle dénitrification
|
WO2010080769A2
(fr)
*
|
2009-01-06 |
2010-07-15 |
Arresto Biosciences, Inc. |
Procédés et compositions chimiothérapeutiques
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
US8691760B2
(en)
|
2009-02-02 |
2014-04-08 |
Ramot At Tel-Aviv University |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(fr)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Procédé et trousses pour déterminer la sensibilité ou la résistance d'un cancer prostatique à une radiothérapie
|
US8828722B2
(en)
|
2009-02-26 |
2014-09-09 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Isolated populations of renal stem cells and methods of isolating and using same
|
MX351466B
(es)
|
2009-03-02 |
2017-10-16 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados, y metodos para usarlos para incrementar el rendimiento de una planta y/o caracteristicas agricolas.
|
EP3026057A3
(fr)
|
2009-03-09 |
2016-08-31 |
Ramot at Tel Aviv University Ltd. |
Compositions pour la prévention et le traitement de maladies neurodégénératives
|
WO2010103517A1
(fr)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions solubles pour le traitement de maladies associées aux ligands cxcr3
|
US20120020954A1
(en)
|
2009-03-30 |
2012-01-26 |
Anat Achiron |
Methods of predicting clinical course and treating multiple sclerosis
|
JP2012522762A
(ja)
|
2009-04-01 |
2012-09-27 |
ザ メディカル リサーチ, インフラストラクチャー, アンド ヘルス サーヴィシーズ ファンド オブ ザ テル アヴィヴ メディカル センター |
ケラチノサイトの増殖および分化を調節する方法
|
CN102612523B
(zh)
|
2009-04-03 |
2016-01-20 |
芝加哥大学 |
与蛋白a(spa)变体相关的组合物和方法
|
WO2010116375A1
(fr)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Peptides isolés pour réguler l'apoptose
|
RU2016134843A
(ru)
|
2009-04-30 |
2018-12-11 |
Тел Хашомер Медикал Рисерч Инфрастракче Энд Сервисиз Лтд. |
Антитела к ceacam1 и способы их использования
|
CN102576024B
(zh)
|
2009-05-19 |
2016-10-26 |
泽蒂克科技有限公司 |
宫颈癌细胞和/或组织的鉴别染色的试剂盒和方法
|
EP2433132B1
(fr)
|
2009-05-21 |
2018-02-21 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Compositions et méthodes pour la détection de l'infection hiv-1/hiv-2
|
CN102639146A
(zh)
|
2009-05-27 |
2012-08-15 |
耶达研究及发展有限公司 |
蛋白酶体抑制剂及其用途
|
WO2010137013A1
(fr)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Unités cristallisées de photosystème i dérivées du pois et leur utilisation dans des dispositifs solides
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
WO2010137020A1
(fr)
|
2009-05-28 |
2010-12-02 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement d'inflammation
|
MX339869B
(es)
|
2009-06-10 |
2016-06-15 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para mejorar la eficacia en el uso de nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico.
|
IN2012DN00715A
(fr)
|
2009-06-24 |
2015-06-19 |
Health Corp Rambam |
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(fr)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions et méthodes de traitement du cancer
|
EP2457089B1
(fr)
|
2009-07-21 |
2019-08-07 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Méthode de diagnostic du cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
EP2467470A2
(fr)
|
2009-08-17 |
2012-06-27 |
Technion Research & Development Foundation Ltd. |
Cellules progénitrices de péricyte et leurs procédés de génération et d'utilisation
|
JP2013502228A
(ja)
*
|
2009-08-21 |
2013-01-24 |
ギリアド バイオロジクス,インク. |
invitroスクリーニングアッセイ
|
WO2011022670A1
(fr)
*
|
2009-08-21 |
2011-02-24 |
Arresto Biosciences, Inc |
Essais de criblage in vivo
|
EP2467169A4
(fr)
*
|
2009-08-21 |
2013-01-02 |
Gilead Biologics Inc |
Essais de criblage in vivo
|
RU2012110587A
(ru)
*
|
2009-08-21 |
2013-09-27 |
Джилид Байолоджикс, Инк. |
Терапевтические способы и композиции
|
BR112012008078A2
(pt)
|
2009-08-21 |
2017-07-04 |
Beeologics Inc |
prevenção e cura de doenças de inseto benéfico por meio de moléculas transcritas de planta.
|
SG2014004816A
(en)
|
2009-08-21 |
2014-03-28 |
Gilead Biologics Inc |
Catalytic domains from lysyl oxidase and loxl2
|
CN106619515A
(zh)
|
2009-08-27 |
2017-05-10 |
工业研究与发展基金会有限公司 |
脂质体组合物及其用途
|
EP2475784A1
(fr)
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Procédés de diagnostic de la sclérose latérale amyotrophique (sla)
|
US9610331B2
(en)
|
2009-09-08 |
2017-04-04 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
US20120171213A1
(en)
|
2009-09-10 |
2012-07-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
WO2011033506A2
(fr)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Polypeptides pon1 isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition à un organophosphate
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US8212001B2
(en)
|
2009-09-17 |
2012-07-03 |
Ramot At Tel-Aviv University Ltd. |
Peptides for the treatment of oxidative stress related disorders
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
MX353880B
(es)
|
2009-10-14 |
2018-01-31 |
Yissum Research Development Company Of The Hebrew Univ Of Jerusalem Ltd Star |
Composiciones para controlar ácaros varroa en abejas.
|
ES2609006T3
(es)
|
2009-10-16 |
2017-04-18 |
Rutgers, The State University Of New Jersey |
Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
|
US9476060B2
(en)
|
2009-10-21 |
2016-10-25 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
EP4166652A1
(fr)
|
2009-11-12 |
2023-04-19 |
Technion Research & Development Foundation Ltd. |
Milieux de culture, cultures cellulaires et procédés de culture de cellules souches pluripotentes dans un état indifférencié
|
EP2498806B1
(fr)
|
2009-11-12 |
2014-12-31 |
Ramot at Tel-Aviv University Ltd. |
Compositions contenant du pedf et leurs utilisations dans le traitement et la prévention de syndromes liés aux ovaires
|
WO2011058555A1
(fr)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
Procédé d'édition de l'adn dans une cellule et constructions ayant cette capacité
|
US20120230974A1
(en)
|
2009-11-17 |
2012-09-13 |
Protalix Ltd |
Alkaline alpha galactosidase for the treatment of fabry disease
|
WO2011063198A2
(fr)
|
2009-11-20 |
2011-05-26 |
St. Jude Children's Research Hospital |
Procédés et compositions de modulation de l'activité du complexe du récepteur de l'interleukine 35
|
EP2504472A1
(fr)
|
2009-11-24 |
2012-10-03 |
Collplant Ltd. |
Procédé de production de fibres de collagène
|
MX2012006246A
(es)
|
2009-11-30 |
2012-06-19 |
Pluristem Ltd |
Celulas adherentes de placenta y su uso en el tratamiento de enfermedades.
|
WO2011067745A2
(fr)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions et procédés d'amélioration de résistance de plantes au stress abiotique
|
EP2510098B1
(fr)
|
2009-12-09 |
2015-02-11 |
Quark Pharmaceuticals, Inc. |
Méthodes et compositions utilisées pour le traitement de maladies, d'affections ou de lésions du snc
|
BR112012016033B1
(pt)
|
2009-12-28 |
2021-03-09 |
Evogene Ltd. |
métodos de aumento de produção de semente, biomassa, taxa de crescimento, vigor, tolerância à deficiência de nitrogênio, eficiência no uso de nitrogênio e/ou redução do tempo de florescimento de uma planta, e, para produzir uma planta transgênica
|
EP2519239B1
(fr)
|
2009-12-29 |
2017-03-08 |
Gamida Cell Ltd. |
Méthodes d'amplification de la prolifération et de l'activité des cellules tueuses naturelles
|
NZ601324A
(en)
|
2010-01-05 |
2014-10-31 |
Vascular Biogenics Ltd |
Methods for use of a specific anti-angiogenic adenoviral agent
|
US20130052165A1
(en)
|
2010-01-12 |
2013-02-28 |
Livnat Bangio |
Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby
|
CN102822202B
(zh)
|
2010-01-27 |
2015-07-22 |
耶达研究及发展有限公司 |
抑制金属蛋白的抗体
|
RU2015108348A
(ru)
|
2010-02-04 |
2015-07-20 |
Джилид Байолоджикс, Инк. |
Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения
|
WO2011099006A2
(fr)
|
2010-02-11 |
2011-08-18 |
Yeda Research And Development Co. Ltd. |
Systèmes enzymatiques pour la fixation du carbone et procédés de production associés
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
US20130109615A1
(en)
|
2010-02-24 |
2013-05-02 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(fr)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de l'efficacité d'un traitement par anti-vegfa pour des tumeurs solides
|
WO2011107994A1
(fr)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Procédés de mesure de la stabilité d'une protéine
|
EP2545176B1
(fr)
|
2010-03-08 |
2016-05-11 |
Yeda Research and Development Co. Ltd. |
Production de protéines recombinantes dans des systèmes hétérologues
|
PL2545182T4
(pl)
|
2010-03-08 |
2017-11-30 |
Monsanto Technology Llc |
Cząsteczki polinukeotydu do regulacji genów w roślinach
|
WO2011111050A2
(fr)
|
2010-03-11 |
2011-09-15 |
Jacob Edrei |
Procédés de génération d'hydrogène
|
EP2555794A4
(fr)
|
2010-04-05 |
2014-01-15 |
Univ Chicago |
COMPOSITIONS ET PROCÉDÉS LIÉS AUX ANTICORPS DE LA PROTÉINE A (SpA) EN TANT QUE AMPLIFICATEUR DE LA RÉPONSE IMMUNITAIRE
|
US9073990B2
(en)
|
2010-04-05 |
2015-07-07 |
Bar-Llan University |
Protease-activatable pore-forming polypeptides
|
EP2557913B1
(fr)
|
2010-04-12 |
2016-08-03 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransférase d'une microalgue rouge et utilisations de celle-ci
|
WO2011128897A1
(fr)
|
2010-04-12 |
2011-10-20 |
Technion Research & Development Foundation Ltd. |
Population de cellules progénitrices pancréatiques et leurs méthodes d'isolement et d'utilisation
|
AU2011243958B2
(en)
|
2010-04-18 |
2015-01-22 |
Yeda Research And Development Co. Ltd. |
Molecules and methods of using same for treating ErbB/ErbB ligands associated diseases
|
BR122021002353B1
(pt)
|
2010-04-28 |
2022-08-16 |
Evogene Ltd |
Método de aumento de produção, biomassa, taxa de crescimento, vigor, tolerância ao estresse abiótico e/ou eficiência de uso de nitrogênio de uma planta, e, construto de ácido nucleico isolado
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
WO2011138785A2
(fr)
|
2010-05-05 |
2011-11-10 |
Rappaport Family Institute For Research In The Medical Sciences |
Utilisation thérapeutique de ccl1
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
CA2799307C
(fr)
|
2010-05-13 |
2019-07-02 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Populations isolees de cellules renales adultes et procedes d'isolement et d'utilisation desdites populations
|
EP2575859B1
(fr)
|
2010-06-03 |
2018-09-19 |
Ramot at Tel Aviv University, Ltd. |
Méthodes pour le traitement du diabéte et compositions aptes à ce traitement
|
CA2801849A1
(fr)
|
2010-06-07 |
2011-12-15 |
Osnat Ashur-Fabian |
Methodes et trousses pour le diagnostic d'etats pathologiques associes a l'hypoxie
|
EP2582842A2
(fr)
|
2010-06-16 |
2013-04-24 |
Yissum Research Development Company of The Hebrew University of Jerusalem |
Procédé de diagnostic et de traitement du cancer
|
US20130097731A1
(en)
|
2010-06-16 |
2013-04-18 |
Futuragene Israel Ltd. |
Pest-resistant plants containing a combination of a spider toxin and a chitinase
|
WO2012003474A2
(fr)
|
2010-07-02 |
2012-01-05 |
The University Of Chicago |
Compositions et méthodes associées à des variants de protéine a (spa)
|
ES2817780T3
(es)
|
2010-07-12 |
2021-04-08 |
The State Of Israel Ministry Of Agriculture And Rural Development Agricultural Res Organization A R |
Polinucleótidos aislados y métodos y plantas que usan los mismos para regular la acidez de las plantas
|
US20130189284A1
(en)
|
2010-07-15 |
2013-07-25 |
Technion Research & Development Foundation Ltd. |
Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
WO2012007951A1
(fr)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Entités isolées à affinité élevée dotées d'une spécificité telle que celle des récepteurs de lymphocytes t pour des complexes natifs du cmh de classe ii et peptides auto-antigènes de la décarboxylase de l'acide glutamique (gad)
|
BR112013000984A2
(pt)
|
2010-07-15 |
2017-10-03 |
Technion Res & Dev Foundation |
Estrutura de ácido nucleico para o aumento da tolerância ao estresse abiótico em plantas
|
EP2595637B1
(fr)
|
2010-07-22 |
2017-11-01 |
Cellect Biotherapeutics Ltd. |
Cellules immunitaires régulatrices possédant un effet de destruction cellulaire ciblé accru
|
WO2012014205A1
(fr)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Cellules progénitrices mésenchymateuses isolées et matrice extra-cellulaire produite au moyen de celles-ci
|
JP2013535966A
(ja)
|
2010-07-27 |
2013-09-19 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
引き抜かれた毛包由来のケラチン生成細胞から誘導多能性幹細胞を生成させる方法
|
WO2012014208A2
(fr)
|
2010-07-27 |
2012-02-02 |
Yeda Research And Development Co. Ltd. |
Procédés et systèmes d'estimation de la clonalité de cultures cellulaires
|
US8901074B2
(en)
|
2010-08-04 |
2014-12-02 |
Ramot At Tel-Aviv University |
Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
|
WO2012025914A1
(fr)
|
2010-08-22 |
2012-03-01 |
Ramot At Tel-Aviv University Ltd. |
Cellules souches pluripotentes induites dérivées de cellules bêta pancréatiques humaines
|
WO2012025925A1
(fr)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Procédés d'amélioration de la transplantation en utilisant des sdf-1alpha
|
US10457954B2
(en)
|
2010-08-30 |
2019-10-29 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
US10214722B2
(en)
|
2010-09-07 |
2019-02-26 |
Technion Research & Development Foundation Limited |
Methods for expanding and maintaining human pluripotent stem cells (PSCs) in an undifferentiated state in a single cell suspension culture
|
WO2012032510A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Amorces pour l'amplification d'adn et procédés de sélection de ces dernières
|
WO2012032520A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Translecture d'acétylcholinestérase (ache-r) pour le traitement ou la prévention de la maladie de parkinson
|
WO2012032519A2
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de diagnostic de la maladie de parkinson
|
ES2589678T3
(es)
|
2010-09-08 |
2016-11-15 |
Yeda Research And Development Co. Ltd. |
Uso de linfocitos T de memoria central anti-terceros para el tratamiento anti-leucemia/linfoma
|
CN103270050A
(zh)
|
2010-09-08 |
2013-08-28 |
耶达研究及发展有限公司 |
用于稳定和长期移植的免疫抑制药物组合
|
EP2614074A1
(fr)
|
2010-09-09 |
2013-07-17 |
The University of Chicago |
Procédés et compositions impliquant des antigènes staphylococciques protecteurs
|
EP2616539A1
(fr)
|
2010-09-15 |
2013-07-24 |
Ramot at Tel-Aviv University Ltd. |
Procédés d'expansion et de redifférenciation de cellules bêta des îlots
|
WO2012038956A1
(fr)
|
2010-09-20 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de traitement de maladies neurodégénératives
|
EP3075396A1
(fr)
|
2010-10-17 |
2016-10-05 |
Yeda Research and Development Co. Ltd. |
Procédés et compositions utilisables en vue du traitement de pathologies médicales associées à l'insuline
|
WO2012052878A1
(fr)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Polynucléotides isolés et constructions d'acide nucléique pour diriger l'expression d'un gène d'intérêt dans des cellules
|
US20130216603A1
(en)
|
2010-10-27 |
2013-08-22 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
CN103370337B
(zh)
|
2010-10-28 |
2015-12-09 |
耶达研究及发展有限公司 |
用于产生针对金属酶的抗体的方法
|
CN103237895A
(zh)
|
2010-11-03 |
2013-08-07 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
具有提高的糖化产率的转基因植物以及产生其的方法
|
WO2012059925A2
(fr)
|
2010-11-04 |
2012-05-10 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-coa: gène de type diacylglycérol acyltransférase 1 (ptdgat1) et utilisations de celui-ci
|
TW201225972A
(en)
|
2010-11-15 |
2012-07-01 |
Univ Ramot |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
WO2012066495A2
(fr)
|
2010-11-17 |
2012-05-24 |
Ben Gurion University Of The Negev Research And Development Authority |
Thérapie à base de cellules t pour les maladies neurodégénératives
|
WO2012075111A1
(fr)
|
2010-11-30 |
2012-06-07 |
Novartis Ag |
Utilisation d'anticorps anti-cd40 en thérapie combinée contre des cancers associés aux cellules b
|
EP2646543A4
(fr)
|
2010-12-02 |
2014-09-03 |
Technion Res & Dev Foundation |
Procédé de génération de cellules cornéennes et populations de cellules les comprenant
|
US20120183960A1
(en)
|
2010-12-07 |
2012-07-19 |
Enterologics, Inc. |
Method for identifying e. coli m-17
|
WO2012081029A1
(fr)
|
2010-12-15 |
2012-06-21 |
Kadimastem Ltd. |
Cellules produisant de l'insuline dérivées de cellules souches pluripotentes
|
CA3095614A1
(fr)
|
2010-12-22 |
2012-06-28 |
Evogene Ltd. |
Polynucleotides et polypeptides isoles, et procedes d'utilisation de ceux-ci pour augmenter la tolerance vis-a-vis du stress abiotique, le rendement, le taux de croissance, la vigueur, la biomasse, la teneur en huile et/ou l'efficacite d'utilisation d'azote de plantes
|
EP2658562B1
(fr)
|
2010-12-28 |
2017-07-26 |
Kamedis Ltd. |
Extraits de plantes pour le traitement et prévention d'infections
|
RS60129B1
(sr)
|
2011-01-20 |
2020-05-29 |
Protalix Ltd |
Kompozicije alfa-galaktozidaze
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
WO2012114339A1
(fr)
|
2011-02-23 |
2012-08-30 |
Rappaport Family Institute For Research In The Medical Sciences |
Molécules de haute affinité capables de se lier à un récepteur plexine de type a et leurs utilisations
|
EP2492279A1
(fr)
|
2011-02-25 |
2012-08-29 |
Laboratorios Del. Dr. Esteve, S.A. |
Procédé de sélection rapide d'immunogène par expression à la surface du lentivirus.
|
US9856492B2
(en)
|
2011-03-02 |
2018-01-02 |
Futuragene Israel Ltd. |
Bacterial resistant transgenic plants having dysfunctional T3SS proteins
|
WO2012117373A1
(fr)
|
2011-03-03 |
2012-09-07 |
Ramot At Tel-Aviv University Ltd. |
Cellules musculaires génétiquement modifiées qui expriment des facteurs neurotrophiques
|
BR112013022832A2
(pt)
|
2011-03-06 |
2016-11-22 |
Merck Serono Sa |
linhagens de células de baixo teor de fucose e usos das mesmas
|
US9061006B2
(en)
|
2011-03-08 |
2015-06-23 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (PKU)
|
MX342135B
(es)
|
2011-03-17 |
2016-09-14 |
Ramot At Tel-Aviv Univ Ltd |
Anticuerpos asimetricos, biespecificos y monoespecificos, y metodos para generar los mismos.
|
EP2685976B1
(fr)
|
2011-03-17 |
2017-12-27 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Analogues de quinolone pour le traitement de maladies auto-immunes
|
JP6030114B2
(ja)
|
2011-03-22 |
2016-11-24 |
プルリステム リミテッド |
放射線照射または化学物質による傷害を治療するための方法
|
KR20140036164A
(ko)
|
2011-03-24 |
2014-03-25 |
뉴림 파머슈티칼스 (1991) 리미티드 |
신경보호 펩타이드
|
WO2012131680A2
(fr)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions et procédés pour le traitement de l'inflammation
|
WO2012137202A1
(fr)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci)
|
JP5990254B2
(ja)
|
2011-04-06 |
2016-09-07 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッドRamot At Tel Aviv University Ltd. |
代謝活性プロフィルのモニタリング方法および分析方法ならびにそれらの診断使用および治療使用
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
ES2768296T3
(es)
|
2011-04-15 |
2020-06-22 |
Pluristem Ltd |
Métodos y sistemas para recoger células
|
US10760088B2
(en)
|
2011-05-03 |
2020-09-01 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
US9192670B2
(en)
|
2011-05-04 |
2015-11-24 |
Ramot At Tel-Aviv University Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
WO2012153333A1
(fr)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Régénération et réparation de tissu mésenchymateux par utilisation d'amélogénine
|
WO2012153336A2
(fr)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Procédés et dispositifs pour éclaircir la carnation de la peau
|
WO2012156976A1
(fr)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de préparation d'artémisinine dans des plantes non-hôtes et vecteurs destinés à une utilisation dans celles-ci
|
WO2012160526A2
(fr)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations à base de particules contenant des micro-organismes et leurs utilisations
|
EP2715350B1
(fr)
|
2011-05-23 |
2017-09-27 |
Yeda Research and Development Co. Ltd. |
Utilisation de la phosphorylation d'akt en tant que biomarqueur pour le pronostic et le traitement de maladies neurodégénératives
|
WO2012164380A2
(fr)
|
2011-05-31 |
2012-12-06 |
Hutchison Biofilm Medical Solutions Limited |
Dispersion et détachement d'agrégats cellulaires
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
WO2012172555A1
(fr)
|
2011-06-14 |
2012-12-20 |
Yeda Research And Development Co. Ltd. |
Plurithérapie destinée à empêcher la formation de dcis et l'évolution en un cancer du sein
|
AR086989A1
(es)
|
2011-06-23 |
2014-02-05 |
Kaiima Bio Agritech Ltd |
Trigo comun: sus plantas o partes que tienen un genoma parcial o completamente multiplicado, sus hibridos y productos y metodos para generarlos y utilizarlos
|
LT2734545T
(lt)
|
2011-07-18 |
2019-05-10 |
Institute For Research In Biomedicine |
Antikūnai, neutralizuojantys influenza a virusą, ir jų panaudojimo būdai
|
CA2841722A1
(fr)
|
2011-07-20 |
2013-01-24 |
Kaiima Bio Agritech Ltd. |
Plantes de mais ayant un genome partiellement ou totalement multiplie et utilisations de celles-ci
|
US20130030452A1
(en)
|
2011-07-27 |
2013-01-31 |
Health Corporation - Rambam |
Devices for surgical applications
|
HUE033746T2
(en)
|
2011-08-04 |
2018-01-29 |
Yeda Res & Dev |
MIR-135 and compositions thereof for the treatment of therapeutic conditions associated with serotonin
|
WO2013021389A2
(fr)
|
2011-08-09 |
2013-02-14 |
Yeda Research And Development Co.Ltd. |
Régulation à la baisse de mir-7 pour favoriser la différenciation des cellules bêta et la production d'insuline
|
RU2014108930A
(ru)
|
2011-08-14 |
2015-09-20 |
Каиима Био Агритех Лтд. |
Растения твердой пшеницы, обладающие частично или полностью умноженным геномом, и их применения
|
EP2753367A4
(fr)
|
2011-09-07 |
2015-10-14 |
Yeda Res & Dev |
Signature olfactive et mélange odorant la contenant
|
CA2848121C
(fr)
|
2011-09-08 |
2022-07-05 |
Yeda Research And Development Co. Ltd. |
Lymphocytes t memoires centraux anti-tierce partie, leurs procedes de production et leur utilisation dans le cadre d'une transplantation ou du traitement d'une maladie
|
CN103890195A
(zh)
|
2011-09-08 |
2014-06-25 |
耶达研究及发展有限公司 |
用于肺癌的新型风险生物标志物
|
ES2645927T3
(es)
|
2011-09-13 |
2017-12-11 |
Monsanto Technology Llc |
Procedimientos y composiciones para el control de malezas
|
AR088155A1
(es)
|
2011-09-13 |
2014-05-14 |
Monsanto Technology Llc |
Metodos y composiciones para el control de malezas
|
WO2013040033A1
(fr)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Procédés et compositions de lutte contre les mauvaises herbes
|
AU2012308694B2
(en)
|
2011-09-13 |
2018-06-14 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2013054320A1
(fr)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
|
DK2768851T3
(en)
|
2011-10-21 |
2017-09-18 |
Augurex Life Sciences Corp |
ANTIGENS DERIVED BY CITRULLINATED 14-3-3 AND APPLICATIONS THEREOF IN THE DIAGNOSIS OF RHEUMATOID ARTHRITIS
|
EP2771464B1
(fr)
|
2011-10-27 |
2018-03-21 |
Yeda Research and Development Co. Ltd. |
Procédés de traitement du cancer
|
BR112014010769B1
(pt)
|
2011-11-03 |
2021-08-03 |
Quark Pharmaceuticals, Inc |
Uso de um composto de rna de fita dupla para preparar um medicamento para tratar doença de ménière
|
EP2776565A1
(fr)
|
2011-11-08 |
2014-09-17 |
Quark Pharmaceuticals, Inc. |
Méthodes et compositions destinées à traiter des maladies, des troubles ou une lésion du système nerveux
|
WO2013076729A1
(fr)
|
2011-11-23 |
2013-05-30 |
Danziger Dan Flower Farm |
Plantes de type otomeria
|
WO2013076730A1
(fr)
|
2011-11-27 |
2013-05-30 |
Yeda Research And Development Co. Ltd. |
Méthodes de régulation de l'angiogenèse et compositions capables de réguler l'angiogenèse
|
AU2012348574A1
(en)
|
2011-12-08 |
2014-07-24 |
Yeda Research And Development Co. Ltd. |
Mammalian fetal pulmonary cells and therapeutic use of same
|
WO2013093921A1
(fr)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Fibres de polymère synthétique enrobées de collagène
|
US20130164193A1
(en)
|
2011-12-22 |
2013-06-27 |
Life Technologies Corporation |
Sequential lateral flow capillary device for analyte determination
|
DK2793914T3
(da)
|
2011-12-22 |
2021-04-26 |
Yeda Res & Dev |
Kombinationsterapi til en stabil og langvarig transplantation
|
CN104270939A
(zh)
|
2011-12-28 |
2015-01-07 |
凯伊玛生物农业科技有限公司 |
具有部分加倍或完全加倍的基因组的栽培高粱植物及其应用
|
WO2013098813A1
(fr)
|
2012-01-01 |
2013-07-04 |
Qbi Enterprises Ltd. |
Particules ciblant endo180 pour l'administration sélective d'agents thérapeutiques et diagnostiques
|
WO2013114363A2
(fr)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Agents antimicrobiens
|
WO2013114371A1
(fr)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Formulation en poudre sèche de dnase i
|
WO2013118120A2
(fr)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Polynucléotides isolés exprimant ou modulant des microarn ou des cibles de ceux-ci, plantes transgéniques comprenant ceux-ci et leurs utilisations dans l'amélioration de l'efficacité d'utilisation de l'azote, de la tolérance au stress abiotique, de la biomasse, de la vigueur ou du rendement d'une plante
|
EP2814951B1
(fr)
|
2012-02-13 |
2019-04-03 |
Gamida-Cell Ltd. |
Culture de cellules souches mésenchymateuses
|
EA201790960A3
(ru)
|
2012-02-14 |
2018-01-31 |
Опко Байолоджикс Лтд. |
Факторы свертывания крови пролонгированного действия и способы их получения
|
CN104245725A
(zh)
|
2012-02-19 |
2014-12-24 |
波塔力克斯有限公司 |
用于治疗高雪氏症的口服单位剂型及其用途
|
US9803175B2
(en)
|
2012-02-22 |
2017-10-31 |
Exostem Biotec Ltd. |
Generation of neural stem cells and motor neurons
|
US10034902B2
(en)
|
2012-02-22 |
2018-07-31 |
Exostem Biotec Ltd. |
MicroRNAs for the generation of astrocytes
|
EP2833714A1
(fr)
|
2012-03-01 |
2015-02-11 |
The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Plantes d'ail stérile mâle, descendance hybride de celles-ci et procédés de génération et d'utilisation de celles-ci
|
CN104411724B
(zh)
|
2012-03-07 |
2018-08-31 |
耶达研究及发展有限公司 |
抑制静止素巯基氧化酶(qsox1)的组合物及其用途
|
WO2013140247A1
(fr)
|
2012-03-20 |
2013-09-26 |
Humabs Biomed Sa |
Anticorps qui neutralisent rsv, mpv et pvm et leurs utilisations
|
WO2013140389A1
(fr)
|
2012-03-22 |
2013-09-26 |
Ramot At Tel-Aviv University Ltd. |
Peptides multimères plif et utilisations de ceux-ci
|
US9283272B2
(en)
|
2012-03-30 |
2016-03-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Targeting intracellular target-binding determinants with intracellular antibodies
|
IN2014MN01886A
(fr)
|
2012-04-18 |
2015-07-10 |
Univ Ramot |
|
MY167814A
(en)
|
2012-04-19 |
2018-09-26 |
Opko Biologics Ltd |
Long-acting oxyntomodulin variants and methods of producing same
|
US9439942B2
(en)
|
2012-04-24 |
2016-09-13 |
Biokine Therapeutics Ltd. |
Peptides and use thereof in the treatment of large cell lung cancer
|
BR112014026861A2
(pt)
|
2012-04-26 |
2018-05-15 |
Univ Chicago |
antígenos de estafilococos coagulase e métodos de seu uso
|
JP6181158B2
(ja)
|
2012-05-09 |
2017-08-16 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
TNF−α阻害剤としてのTACEプロドメインの変異体およびその医学的使用
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
CN104619843B
(zh)
|
2012-05-24 |
2020-03-06 |
A.B.种子有限公司 |
用于使基因表达沉默的组合物和方法
|
EP3508497A1
(fr)
|
2012-05-24 |
2019-07-10 |
Mountgate Group Limited |
Compositions et procédés associés à la prévention et au traitement d'une infection rabique
|
WO2013183048A1
(fr)
|
2012-06-03 |
2013-12-12 |
Ben-Gurion University Of The Negev Research And Development Authority |
Peptides de liaison au titane fonctionnalisés et implants revêtus par ceux-ci
|
SG10201702228QA
(en)
|
2012-06-04 |
2017-04-27 |
Opko Biolog Ltd |
Pegylated oxm variants
|
US10023474B2
(en)
|
2012-07-03 |
2018-07-17 |
Nanospun Technologies Ltd. |
Methods for adsorption and biodegradation of petroleum
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
EP2880155B1
(fr)
|
2012-07-29 |
2019-04-17 |
Yeda Research and Development Co., Ltd. |
Utilisation de la voie de la glycine réductrice en vue de la génération de microorganismes formatotrophes et autotrophes
|
EP2879678B1
(fr)
|
2012-07-31 |
2023-03-01 |
Yeda Research and Development Co. Ltd. |
Enoxacin pour le traitement de la sclérose latérale amyotrophique
|
CA2877223C
(fr)
|
2012-08-06 |
2019-08-27 |
Brainstorm Cell Therapeutics Ltd. |
Procedes de generation de cellules souches mesechymateuses qui secretent des facteurs neurotrophiques
|
EP2698377A1
(fr)
|
2012-08-17 |
2014-02-19 |
Laboratorios Del. Dr. Esteve, S.A. |
Procédé de sélection rapide d'immunogène de variants de la GP-120 du VIH amélioré
|
WO2014033723A1
(fr)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Procédé d'amélioration de la tolérance au stress abiotique des plantes et plantes ainsi produites
|
WO2014041544A1
(fr)
|
2012-09-12 |
2014-03-20 |
Ramot At Tel-Aviv University Ltd. |
Immunoparticules et procédés pour les produire et les utiliser
|
EP2900685B1
(fr)
|
2012-09-27 |
2017-10-25 |
Research Development Foundation |
Virus atténué de chikungunya
|
EP2906954B1
(fr)
|
2012-10-09 |
2018-04-11 |
Ramot at Tel-Aviv University Ltd. |
Procédés et trousses utilisant la mortaline soluble dans le sang pour prédire un pronostic de cancer
|
CN104918639B
(zh)
|
2012-10-22 |
2018-01-26 |
萨拜格Rfa公司 |
用于将治疗剂递送到活细胞和细胞核中的系统
|
WO2014064682A1
(fr)
|
2012-10-24 |
2014-05-01 |
Yeda Research And Development Co. Ltd. |
Combinaisons d'anticorps ciblant les récepteurs du facteur de croissance épidermique pour traiter le cancer
|
EP2912181B1
(fr)
|
2012-10-29 |
2017-11-29 |
Yeda Research and Development Co., Ltd. |
Aptamères, aptamères multimères et leurs utilisations
|
WO2014080401A2
(fr)
|
2012-11-20 |
2014-05-30 |
Prolor Biotech Inc |
Procédé d'augmentation du volume hydrodynamique de polypeptides par la fixation à des peptides carboxy terminaux de gonadotrophine
|
IN2014MN02655A
(fr)
|
2012-11-29 |
2015-08-21 |
Yeda Res & Dev |
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
US10041068B2
(en)
|
2013-01-01 |
2018-08-07 |
A. B. Seeds Ltd. |
Isolated dsRNA molecules and methods of using same for silencing target molecules of interest
|
WO2014108850A2
(fr)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
Analyse de transcriptome à haut débit
|
WO2014108854A1
(fr)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Anticorps anti-hgf et anti-ang2 monospécifiques, et anticorps anti-hgf/anti-ang2 bispécifiques
|
JP6411372B2
(ja)
|
2013-01-17 |
2018-10-24 |
ノベルラスディクス リミテッド |
患者特有のドライバー変異を特定するための方法およびシステム
|
WO2014118785A1
(fr)
|
2013-02-04 |
2014-08-07 |
Ramot At Tel-Aviv University Ltd. |
Génération de lignées cellulaires spécifiques d'une tumeur cytotoxiques et leurs utilisations
|
US20160017021A1
(en)
|
2013-03-06 |
2016-01-21 |
Protalix Ltd. |
TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
|
CN105121460A
(zh)
|
2013-03-06 |
2015-12-02 |
波塔力克斯有限公司 |
表达TNFα多肽抑制的植物细胞在治疗中的用途
|
EP2964254B1
(fr)
|
2013-03-07 |
2019-09-18 |
University of Maryland, Baltimore |
Potentiel immunothérapeutique de lipooligosaccharides/lipide a modifiés
|
WO2014164761A1
(fr)
|
2013-03-13 |
2014-10-09 |
Monsanto Technology Llc |
Procédés et compositions utilisables pour lutter contre les mauvaises herbes
|
AU2014248958A1
(en)
|
2013-03-13 |
2015-10-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
ES2883580T3
(es)
|
2013-03-21 |
2021-12-09 |
Collplant Ltd |
Composiciones que comprenden colágeno y PRP para la regeneración de tejidos y su método de producción
|
WO2014155376A1
(fr)
|
2013-03-24 |
2014-10-02 |
Biokine Therapeutics Ltd. |
Méthodes de traitement de la leucémie myéloïde
|
US20160122758A1
(en)
|
2013-04-21 |
2016-05-05 |
Yeda Research And Development Co. Ltd. |
Agents for downregulation of the activity and/or amount of bcl-xl and/or bcl-w
|
ES2831424T3
(es)
|
2013-04-23 |
2021-06-08 |
Yeda Res & Dev |
Células madre pluripotentes naif aisladas y métodos para generarlas
|
US9714268B2
(en)
|
2013-04-25 |
2017-07-25 |
Yeda Research And Development Co. Ltd. |
Use of inhibitory peptides for the treatment of inflammatory diseases
|
EP2999717B1
(fr)
|
2013-05-21 |
2018-08-08 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Traitement des pathologies impliquant des mastocytes
|
WO2014191995A2
(fr)
|
2013-05-27 |
2014-12-04 |
Rakuto Bio Technologies Ltd. |
Compositions cosmétiques contenant un système enzymatique
|
EP3013380B1
(fr)
|
2013-06-24 |
2022-11-23 |
Ramot at Tel-Aviv University Ltd. |
Échafaudage à base d'épiploon et système d'administration
|
BR112016000555B1
(pt)
|
2013-07-19 |
2022-12-27 |
Monsanto Technology Llc |
Método para controlar uma infestação da espécie de leptinotarsa em uma planta, composição inseticida e construção de dna recombinante
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
WO2015015489A1
(fr)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Anticorps convenant au traitement du diabète et de maladies autoimmunes
|
US9938316B2
(en)
|
2013-08-29 |
2018-04-10 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
WO2015033344A1
(fr)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et nécessaires permettant d'inhiber la pathogénicité d'un streptocoque du groupe a (sga) ou d'un streptocoque du groupe g (sgg)
|
WO2015037009A1
(fr)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Protéines isolées capables de se lier à la plexine-a4, et procédés de production et d'utilisation
|
ES2717446T3
(es)
|
2013-09-17 |
2019-06-21 |
Yeda Res & Dev |
Péptidos derivados de ERK y usos de los mismos
|
ES2796853T3
(es)
|
2013-10-01 |
2020-11-30 |
Kadimastem Ltd |
Diferenciación dirigida de astrocitos a partir de células madre pluripotentes humanas para uso en el cribado de medicamentos y el tratamiento de la esclerosis lateral amiotrófica (ELA)
|
KR102357635B1
(ko)
|
2013-10-02 |
2022-01-28 |
메디뮨 엘엘씨 |
중화 항-인플루엔자 a 항체 및 이의 용도
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
PT3060239T
(pt)
|
2013-10-21 |
2020-08-26 |
Opko Biologics Ltd |
Polipéptidos de ação prolongada e métodos de produção e administração dos mesmos
|
EP3060656A1
(fr)
|
2013-10-24 |
2016-08-31 |
Yeda Research and Development Co., Ltd. |
Polynucléotides codant pour des polypeptides de système brex et leurs méthodes d'utilisation
|
JP6505681B2
(ja)
|
2013-10-31 |
2019-04-24 |
バイオカイン セラピューティックス リミテッド |
Flt3変異を有する急性骨髄性白血病を治療するための医薬組成物
|
UY35817A
(es)
|
2013-11-04 |
2015-05-29 |
Us Agriculture |
?composiciones y métodos para controlar infestaciones de plagas y parásitos de los artrópodos?.
|
EP3074391B1
(fr)
|
2013-11-28 |
2019-07-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Inhibiteurs de l'arn polymérase i et leurs utilisations
|
EP3074044A2
(fr)
|
2013-11-28 |
2016-10-05 |
Yeda Research and Development Co., Ltd. |
Inhibiteurs de synaptojanine-2 et leurs utilisations
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
WO2015087327A1
(fr)
|
2013-12-10 |
2015-06-18 |
Yeda Research And Development Co. Ltd. |
Utilisation d'enzymes catalysant la synthèse de pyruvate à partir de formiate et d'acétyl-coa et bactéries les exprimant
|
CN105979770B
(zh)
|
2014-01-15 |
2019-07-05 |
孟山都技术公司 |
用于使用epsps多核苷酸的杂草控制的方法和组合物
|
WO2015114633A1
(fr)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Peptides se liant à l'actine et compositions les contenant pour inhiber l'angiogenèse et traiter des affections médicales associées à celle-ci
|
CN106470699A
(zh)
|
2014-02-03 |
2017-03-01 |
耶路撒冷希伯来大学的益生研究开发有限公司 |
使用酪蛋白激酶i抑制剂以消耗干细胞的用途
|
US10125365B2
(en)
|
2014-02-05 |
2018-11-13 |
Yeda Research And Development Co. Ltd. |
Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
WO2015118538A1
(fr)
|
2014-02-06 |
2015-08-13 |
Yeda Research And Development Co. Ltd. |
Anticorps anti cd84, compositions les comprenant et leurs utilisations
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
EP3105587B1
(fr)
|
2014-02-11 |
2023-09-06 |
Brainstorm Cell Therapeutics Ltd. |
Procédé de qualification de cellules
|
WO2015132784A1
(fr)
|
2014-03-03 |
2015-09-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé et dispositif de détection de pseudomonas aeruginosa
|
EP2923709A1
(fr)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
EP3420809A1
(fr)
|
2014-04-01 |
2019-01-02 |
Monsanto Technology LLC |
Compositions et procédés pour lutter contre les insectes nuisibles
|
WO2015155777A1
(fr)
|
2014-04-10 |
2015-10-15 |
Bonus Therapeutics Ltd. |
Compositions pour la réparation des os
|
SI4026917T1
(sl)
|
2014-04-14 |
2024-05-31 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Metoda in komplet za določanje smrti celic ali tkiva oz. izvora DNK tkiva ali celice z analizo metilacije DNK
|
US10590467B2
(en)
|
2014-04-17 |
2020-03-17 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing DNA binding moieties attached to DNA
|
AP2016009564A0
(en)
|
2014-04-27 |
2016-11-30 |
Ccam Biotherapeutics Ltd |
Humanized antibodies against ceacam1
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
WO2015166492A2
(fr)
|
2014-04-28 |
2015-11-05 |
Yeda Research And Development Co. Ltd. |
Réponse du microbiome à des agents
|
US20170191065A1
(en)
|
2014-05-04 |
2017-07-06 |
Forrest Innovations Ltd. |
Compositions and methods of using same for increasing resistance of infected mosquitoes
|
US10993990B2
(en)
|
2014-05-16 |
2021-05-04 |
Baylor Research Institute |
Methods and compositions for treating autoimmune and inflammatory conditions
|
EP3145947A2
(fr)
|
2014-05-22 |
2017-03-29 |
Yeda Research and Development Co., Ltd. |
Micro-organismes recombinés pouvant fixer le carbone
|
WO2015186129A1
(fr)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions et procédés d'inhibition sélective d'irp1 et traitement de l'inflammation
|
US20170095512A1
(en)
|
2014-06-02 |
2017-04-06 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
CA2953347A1
(fr)
|
2014-06-23 |
2015-12-30 |
Monsanto Technology Llc |
Compositions et methodes de regulation de l'expression genetique par interference par arn
|
EP3145951A1
(fr)
|
2014-06-24 |
2017-03-29 |
InSight Biopharmaceuticals Ltd. |
Procédés de purification d'anticorps
|
WO2015200539A1
(fr)
|
2014-06-25 |
2015-12-30 |
Monsanto Technology Llc |
Procédés et compositions pour administrer des acides nucléiques à des cellules végétales et réguler l'expression génique
|
AU2015278659A1
(en)
|
2014-06-25 |
2017-02-02 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Identification of cancer stem cell markers and use of same for diagnosis and treatment
|
WO2015198326A1
(fr)
|
2014-06-26 |
2015-12-30 |
Ramot At Tel-Aviv University Ltd. |
Formulations de liposome pour l'administration d'acides nucléiques
|
WO2016005985A2
(fr)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode pour reprogrammer des cellules
|
WO2016011035A2
(fr)
|
2014-07-15 |
2016-01-21 |
Medlmmune, Llc |
Neutralisation d'anticorps anti-grippe b et leurs utilisations
|
ES2799404T3
(es)
|
2014-07-15 |
2020-12-17 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
Polipéptidos de CD44 aislados y usos de los mismos
|
EP3172562B1
(fr)
|
2014-07-21 |
2019-03-13 |
Novellusdx Ltd. |
Procédés et systèmes pour déterminer un indice oncogénique de mutations spécifiques d'un patient
|
CN106715719B
(zh)
|
2014-07-21 |
2022-08-02 |
福尔生物治疗有限公司 |
用于确定患者特定突变的药物反应的方法
|
WO2016018887A1
(fr)
|
2014-07-29 |
2016-02-04 |
Monsanto Technology Llc |
Compositions et méthodes pour lutter contre les insectes nuisibles
|
EP3194572B1
(fr)
|
2014-07-30 |
2023-10-25 |
Yeda Research and Development Co. Ltd. |
Milieux pour la culture de cellules souches pluripotentes
|
CA2954601C
(fr)
|
2014-08-14 |
2023-04-18 |
Memed Diagnostics Ltd. |
Analyse computationnelle de donnees biologiques au moyen d'un collecteur et d'un hyperplan
|
WO2016030899A1
(fr)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement de la sclérose latérale amyotrophique
|
EP2992895A1
(fr)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
US10526416B2
(en)
|
2014-09-08 |
2020-01-07 |
Yeda Research And Development Co. Ltd. |
Anti-HER3 antibodies and uses of same
|
EP3191523B1
(fr)
|
2014-09-08 |
2019-08-07 |
Yeda Research and Development Co., Ltd. |
Compositions et procédés de traitement d'un cancer résistant à un inhibiteur de la tyrosine kinase (tki)
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
EP3230453B1
(fr)
|
2014-09-21 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Freination du mir-132 pour le traitement de troubles lipidiques
|
US20170296650A1
(en)
|
2014-10-08 |
2017-10-19 |
Novartis Ag |
Combination of human cytomegalovirus neutralizing antibodies
|
EP3209799B1
(fr)
|
2014-10-20 |
2020-07-08 |
Gen-Probe Incorporated |
Solution de lyse de globules rouges
|
AU2015346969B2
(en)
|
2014-11-13 |
2019-03-21 |
Enzootic Holdings Ltd. |
Functional sex-reversal of decapod crustacean females
|
WO2016075546A2
(fr)
|
2014-11-14 |
2016-05-19 |
Antonio Lanzavecchia |
Anticorps qui neutralisent le virus ebola et leurs utilisations
|
EP3220945A2
(fr)
|
2014-11-17 |
2017-09-27 |
Yeda Research and Development Co., Ltd. |
Procédés de traitement de maladies associées à une fonction mitochondriale
|
JP2017533723A
(ja)
|
2014-11-17 |
2017-11-16 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
マイクロバイオーム解析方法
|
US10703801B2
(en)
|
2014-11-18 |
2020-07-07 |
Humabs Biomed Sa |
Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof
|
CN107810271B
(zh)
|
2014-11-20 |
2021-09-28 |
耶路撒冷希伯来大学伊萨姆研发公司 |
用于在植物细胞中生产具有改变的糖基化模式的多肽的组合物和方法
|
JP6860483B2
(ja)
|
2014-11-26 |
2021-04-14 |
テクノロジー イノベーション モメンタム ファンド(イスラエル)リミテッド パートナーシップTechnology Innovation Momentum Fund(israel)Limited Partnership |
細菌遺伝子の標的化削減
|
JP2017535296A
(ja)
|
2014-11-27 |
2017-11-30 |
ダンツィガー イノベイションズ リミテッドDanziger Innovations Ltd. |
ゲノム編集のための核酸構築物
|
WO2016092555A2
(fr)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Polypeptides de phosphotriestérase isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition aux organophosphates
|
WO2016103269A1
(fr)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations de cellules progénitrices neuronales et leurs procédés de production et d'utilisation
|
US20180008458A1
(en)
|
2014-12-30 |
2018-01-11 |
Cell Cure Neurosciences Ltd. |
Methods of treating retinal diseases
|
JP2018502575A
(ja)
|
2014-12-30 |
2018-02-01 |
セル キュア ニューロサイエンシズ リミテッド |
網膜色素上皮細胞集団の評価法
|
WO2016108239A1
(fr)
|
2014-12-30 |
2016-07-07 |
Cell Cure Neurosciences Ltd. |
Populations de cellules de l'epr et leurs procédés de production
|
WO2016108244A1
(fr)
|
2015-01-04 |
2016-07-07 |
Protalix Ltd. |
Dnase modifiée et ses utilisations
|
WO2016116935A1
(fr)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Utilisation de la rasa2 en tant que marqueur pronostique et thérapeutique pour un mélanome
|
CN108064288B
(zh)
|
2015-01-22 |
2021-11-26 |
孟山都技术公司 |
用于控制叶甲属的组合物和方法
|
US20180345047A1
(en)
|
2015-02-26 |
2018-12-06 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
EP3268475B1
(fr)
|
2015-03-11 |
2020-10-21 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Oligonucléotides leurres pour le traitement de maladies
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
AU2016243124A1
(en)
|
2015-03-27 |
2017-11-02 |
University Of Southern California |
CAR T-cell therapy directed to LHR for the treatment of solid tumors
|
US20180064748A1
(en)
|
2015-03-27 |
2018-03-08 |
Yeda Research And Development Co. Ltd. |
Methods of treating motor neuron diseases
|
BR112017021016A2
(pt)
|
2015-03-31 |
2018-07-03 |
Yeda Research And Development Co Ltd |
preparação de proteína, composição farmacêutica, proteína de fusão, polinucleotídeo isolado, estrutura de ácido nucleico, método para tratamento de doença ou condição associada ao excesso de glutamato, e método de purificação de um polipeptídeo
|
EP3277260B1
(fr)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Extraits végétaux de crassifolium erodium l'her et leurs utilisations
|
US10968185B2
(en)
|
2015-04-07 |
2021-04-06 |
Ela Pharma Ltd. |
Substituted thiazoles for preventing and/or treating cell or tissue necrosis
|
EP3081575A1
(fr)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anticorps anti-plasmodium pour parasite
|
ES2951653T3
(es)
|
2015-04-27 |
2023-10-24 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Moléculas dirigidas a EGR1 para el tratamiento de afecciones inflamatorias e hiperproliferativas
|
ES2911341T3
(es)
|
2015-04-29 |
2022-05-18 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Composiciones antifitopatogénicas
|
WO2016174652A1
(fr)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Récepteurs antigéniques chimériques et méthodes d'utilisation correspondantes
|
CN108026566A
(zh)
|
2015-05-04 |
2018-05-11 |
特拉维夫大学拉莫特有限公司 |
用于使dna片段化的方法和试剂盒
|
WO2016181393A1
(fr)
|
2015-05-11 |
2016-11-17 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs de citrine pour le traitement du cancer
|
US11219636B2
(en)
|
2015-05-17 |
2022-01-11 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(fr)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Méthodes pour favoriser la lymphagiogenèse
|
WO2016185481A2
(fr)
|
2015-05-20 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Procédé destiné à cibler des cellules sénescentes
|
US20180140648A1
(en)
|
2015-05-21 |
2018-05-24 |
Yeda Research And Development Co. Ltd. |
Bacterial populations for promoting health
|
JP2018517697A
(ja)
|
2015-05-29 |
2018-07-05 |
オプコ バイオロジクス リミテッド |
ペグ化オキシントモジュリン変異体
|
AU2016271323B2
(en)
|
2015-06-01 |
2022-08-25 |
Medimmune, Llc |
Neutralizing anti-influenza binding molecules and uses thereof
|
AU2016270870A1
(en)
|
2015-06-02 |
2018-01-04 |
Monsanto Technology Llc |
Compositions and methods for delivery of a polynucleotide into a plant
|
WO2016196782A1
(fr)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Procédés et compositions pour l'introduction d'acides nucléiques dans des plantes
|
CA2987992A1
(fr)
|
2015-06-04 |
2016-12-08 |
University Of Southern California |
Immunotherapie des cellules car ciblees par lym-1 et lym-2
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016203476A1
(fr)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et compositions pour le diagnostic et le traitement d'un cancer urothélial
|
EP4026563A1
(fr)
|
2015-06-18 |
2022-07-13 |
Yeda Research and Development Co. Ltd |
Protocoles de conditionnement et utilisation de ceux-ci pour la régénération de tissu
|
HUE055449T2
(hu)
|
2015-06-19 |
2021-11-29 |
Opko Biologics Ltd |
Hosszú hatástartamú koagulációs faktorok és eljárások ezek elõállítására
|
US20180179274A1
(en)
|
2015-06-26 |
2018-06-28 |
Institute For Research In Biomedicine |
Proteins comprising a mutated lair-1 fragment and uses thereof
|
ES2963038T3
(es)
|
2015-07-16 |
2024-03-25 |
Yeda Res & Dev |
Uso de células T de memoria central antitercero
|
CN111375066B
(zh)
|
2015-07-16 |
2023-04-25 |
百欧肯治疗有限公司 |
治疗癌症的组合物及方法
|
WO2017013648A1
(fr)
|
2015-07-19 |
2017-01-26 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs sélectifs des isoformes contenant alpha2 de la na,k-atpase et leur utilisation pour réduire la pression intraoculaire
|
KR102460440B1
(ko)
|
2015-07-22 |
2022-10-28 |
피토파마 인터내셔널 리미티드 |
꿀벌―섭취가능한 조성물, 이를 이용한 꿀 생산 방법 및 이에 의해 생산된 꿀
|
ES2865024T3
(es)
|
2015-07-29 |
2021-10-14 |
Hadasit Med Res Service |
Producción a gran escala de células de epitelio pigmentario retiniano
|
ES2965461T3
(es)
|
2015-08-03 |
2024-04-15 |
Biokine Therapeutics Ltd |
Inhibidor de CXCR4 para el tratamiento del cáncer
|
WO2017021961A1
(fr)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Procédés de criblage pour riborégulateurs et atténuateurs
|
EP3331995A1
(fr)
|
2015-08-05 |
2018-06-13 |
Cell Cure Neurosciences Ltd. |
Préparation de photorécepteurs pour le traitement de maladies rétiniennes
|
EP3331994B1
(fr)
|
2015-08-05 |
2022-09-14 |
Cell Cure Neurosciences Ltd. |
Préparation de cellules de l'épithélium pigmentaire rétinien
|
EP3334449B1
(fr)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Méthodes et compositions pharmaceutiques permettant d'améliorer la cicatrisation des plaies par cd24
|
WO2017025967A1
(fr)
|
2015-08-13 |
2017-02-16 |
Forrest Innovations Ltd. |
Formulations et compositions d'administration d'acides nucléiques à des cellules végétales
|
WO2017033188A1
(fr)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Huile et biocarburant d'origine algale et leurs procédés de production
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042816A1
(fr)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation de cellules dendritiques dont le test est positif pour la perforine, dans le traitement du cancer
|
WO2017059878A1
(fr)
|
2015-10-07 |
2017-04-13 |
Humabs Biomed Sa |
Anticorps neutralisant puissamment le virus de l'hépatite b et utilisations de ces derniers
|
WO2017072757A1
(fr)
|
2015-10-25 |
2017-05-04 |
Yeda Research And Development Co. Ltd. |
Anticorps ciblant la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
|
EP3368661A1
(fr)
|
2015-10-26 |
2018-09-05 |
Cell Cure Neurosciences Ltd. |
Préparation de cellules de l'épithélium pigmentaire rétinien
|
JP7078538B2
(ja)
|
2015-10-27 |
2022-05-31 |
ジェイ ファーマ、インコーポレイティッド |
がんの治療のためのカンナビジオール及び第二の治療剤を含む組成物
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
US20180303974A1
(en)
|
2015-11-03 |
2018-10-25 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
US20180327855A1
(en)
|
2015-11-11 |
2018-11-15 |
Ramot At Tel-Aviv University Ltd. |
Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
|
JP6909230B2
(ja)
|
2015-11-30 |
2021-07-28 |
カディマステム リミテッド |
膵臓内分泌細胞の分化および精製のための方法
|
EP3176183A1
(fr)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions et procédés pour traiter un cancer non résistant à un inhibiteur de la tyrosine kinase (tki)
|
ES2924732T3
(es)
|
2015-12-16 |
2022-10-10 |
Univ Ramot |
Partículas que comprenden epiplón descelularizado
|
EP3397344A4
(fr)
|
2015-12-28 |
2019-08-28 |
B.G. Negev Technologies and Applications Ltd. at Ben-Gurion University |
Composition et méthode pour le traitement de la sclérose latérale amyotrophique
|
JP2019505511A
(ja)
|
2016-01-06 |
2019-02-28 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
悪性疾患、自己免疫疾患および炎症性疾患を処置するための組成物および方法
|
WO2017122203A1
(fr)
|
2016-01-11 |
2017-07-20 |
Technion Research & Development Foundation Limited |
Méthodes de détermination du pronostic de septicémie et traitement associé
|
WO2017123685A1
(fr)
|
2016-01-13 |
2017-07-20 |
Medimmune, Llc |
Méthode de traitement de la grippe a
|
EP3405024B1
(fr)
|
2016-01-21 |
2022-12-28 |
The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Plantes parthénocarpiques et procédés de production de celles-ci
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
EP3408376A1
(fr)
|
2016-01-31 |
2018-12-05 |
Hadasit Medical Research Services and Development Ltd. |
Populations de cellules souches pluripotentes ayant une composition de chromosomes sexuels non identiques et leurs utilisations
|
JP7072508B2
(ja)
|
2016-02-04 |
2022-05-20 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
変異型p53と関連している疾患、障害または病状の処置におけるペプチドおよびその使用
|
WO2017138007A1
(fr)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Diagnostic basé sur le microbiome, prédiction et traitement de l'obésité de rechute
|
US20190046497A1
(en)
|
2016-02-14 |
2019-02-14 |
Yeda Research And Development Co., Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
EP3416488A1
(fr)
|
2016-02-16 |
2018-12-26 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Analogues de phénylalanine non protéiques pour inhiber la croissance végétale et de cyanobactéries
|
WO2017145162A1
(fr)
|
2016-02-23 |
2017-08-31 |
Chaya Brodie |
Production de cellules souches cancéreuses et leur utilisation
|
IL261200B2
(en)
|
2016-03-01 |
2023-03-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Antibodies specific for the human poliovirus receptor
|
CN108699609A
(zh)
|
2016-03-03 |
2018-10-23 |
米密德诊断学有限公司 |
分析rna用于诊断感染类型
|
WO2017153982A1
(fr)
|
2016-03-06 |
2017-09-14 |
Yeda Research And Development Co. Ltd. |
Procédé de modulation de la myélinisation
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
DE202017007129U1
(de)
|
2016-04-27 |
2019-08-29 |
Gen-Probe Incorporated |
Lysereagenz für Blutzellen
|
CN109475581A
(zh)
|
2016-05-22 |
2019-03-15 |
耶达研究及发展有限公司 |
为了移植及诱导耐受性而使用肺细胞的方法
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
WO2017212476A1
(fr)
|
2016-06-05 |
2017-12-14 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Nouvelles molécules destinées au traitement de l'inflammation
|
WO2017212494A1
(fr)
|
2016-06-09 |
2017-12-14 |
Opko Biologics Ltd. |
Formulation d'oxyntomoduline à action prolongée, et procédés de production et procédés d'administration de cette dernière
|
US11859232B2
(en)
|
2016-06-19 |
2024-01-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
SG11201811563RA
(en)
|
2016-06-27 |
2019-01-30 |
Yeda Res & Dev |
Veto cells generated from memory t cells
|
WO2018011796A1
(fr)
|
2016-07-10 |
2018-01-18 |
Memed Diagnostics Ltd. |
Diagnostic précoce d'infections
|
EP4141448A1
(fr)
|
2016-07-10 |
2023-03-01 |
MeMed Diagnostics Ltd. |
Signatures protéiques permettant de faire la distinction entre des infections bactériennes et virales
|
EP3481967A4
(fr)
|
2016-07-11 |
2020-04-22 |
Bonus Therapeutics Ltd. |
Compositions cellulaires pour la régénération tissulaire
|
US11976106B2
(en)
|
2016-07-11 |
2024-05-07 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
US20200080050A1
(en)
|
2016-07-11 |
2020-03-12 |
Yaakov Nahmias |
Systems and methods for growing cells in vitro
|
WO2018010789A1
(fr)
|
2016-07-13 |
2018-01-18 |
Humabs Biomed Sa |
Nouveaux anticorps se liant spécifiquement aux épitopes du virus zika et leurs utilisations
|
EP3484517A4
(fr)
|
2016-07-18 |
2020-04-15 |
Ramot at Tel-Aviv University Ltd. |
Plate-forme modulaire pour thérapie ciblée
|
US20190203270A1
(en)
|
2016-07-24 |
2019-07-04 |
Yeda Research And Development Co., Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
WO2018029682A1
(fr)
|
2016-08-08 |
2018-02-15 |
Ramot At Tel-Aviv University Ltd. |
Systèmes bactériens servant à analyser des polypeptides ubiquitinylés
|
CN109844532B
(zh)
|
2016-08-10 |
2022-06-17 |
米密德诊断学有限公司 |
分析生物数据的系统和方法
|
EP3497239A4
(fr)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Analyse de l'état de méthylation et du nombre de copies
|
PL3496730T3
(pl)
|
2016-08-14 |
2022-09-26 |
Ramot At Tel-Aviv University Ltd. |
Egzosomy pochodzące z komórek mezenchymalnych do leczenia zaburzeń neurologicznych
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(fr)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Procédés et compositions pour le traitement de maladies auto-immunes
|
JP2020501506A
(ja)
|
2016-09-07 |
2020-01-23 |
イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー. |
抗NKp46抗体およびその治療的使用
|
EP3512943B1
(fr)
|
2016-09-14 |
2023-04-12 |
Yeda Research and Development Co. Ltd. |
Crisp-seq, procédé intégré pour séquençage massivement parallèle d'arn unicellulaire et criblages regroupés par crispr
|
EP3519833B1
(fr)
|
2016-09-29 |
2024-08-14 |
MeMed Diagnostics Ltd. |
Méthodes de pronostic et de traitement
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
US10662226B2
(en)
|
2016-10-28 |
2020-05-26 |
The Regents of the University of Caiifomia |
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
|
WO2018087759A1
(fr)
|
2016-11-10 |
2018-05-17 |
Yeda Research And Development Co. Ltd. |
Phosphotriestérases destinés au traitement ou à prévention des dommages associés à l'exposition aux organophosphates
|
EP3545095A1
(fr)
|
2016-11-28 |
2019-10-02 |
Yeda Research and Development Co., Ltd. |
Polynucléotides et polypeptides isolés et procédés pour les utiliser afin d'exprimer un produit d'expression d'intérêt
|
WO2018100574A1
(fr)
|
2016-11-30 |
2018-06-07 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement de maladies et de la toxicité hépathique
|
MX2018016003A
(es)
|
2016-12-01 |
2019-05-16 |
Univ Ramot |
Tratamiento combinado para lesiones neurológicas.
|
US11555178B2
(en)
|
2017-01-18 |
2023-01-17 |
Yeda Research And Development Co. Ltd. |
Genetically modified veto cells and use of same in immunotherapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
WO2018167780A1
(fr)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Méthodes de diagnostic et de traitement du cancer
|
EP3596469A1
(fr)
|
2017-03-12 |
2020-01-22 |
Yeda Research and Development Co., Ltd. |
Procédés de diagnostic et de pronostic du cancer
|
EP3595687A1
(fr)
|
2017-03-16 |
2020-01-22 |
Lineage Cell Therapeutics, Inc. |
Procédés de mesure d'effets thérapeutiques de traitements de maladies rétiniennes
|
JP2020516243A
(ja)
|
2017-04-05 |
2020-06-11 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
エクスビボ培養系およびその使用方法
|
CN110945022B
(zh)
|
2017-04-19 |
2024-04-05 |
生物医学研究所 |
作为疫苗及新疟疾疫苗和抗体结合靶标的疟原虫子孢子npdp肽
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
JP7445429B2
(ja)
|
2017-05-10 |
2024-03-07 |
アリエル サイエンティフィック イノベーションズ リミテッド |
抗体の精製法
|
ES2939298T3
(es)
|
2017-05-21 |
2023-04-20 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Combinación de marcadores para el diagnóstico del cáncer
|
WO2018216011A1
(fr)
|
2017-05-23 |
2018-11-29 |
Technion Research & Development Foundation Limited |
Agents inhibant la dimérisation de gads et leurs procédés d'utilisation
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
WO2018220582A1
(fr)
|
2017-05-31 |
2018-12-06 |
Tropic Biosciences UK Limited |
Méthodes de sélection de cellules comprenant des événements d'édition de génome
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
WO2018229764A1
(fr)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Traitement de la sclérose en plaques avancée ou progressive
|
EP3652344A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Cibles d'adn à titre de marqueurs de méthylation spécifiques de tissu
|
EP3652342A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Détection d'adn spécifique d'un tissu
|
WO2019012544A1
(fr)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Stratégie de pcr en gouttelettes à double sonde pour la détection spécifique de molécules d'adn circulantes spécifiques d'un tissu
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
WO2019038771A1
(fr)
|
2017-08-23 |
2019-02-28 |
Technion Research & Development Foundation Limited |
Compositions et procédés d'amélioration de la tolérance à l'alcool dans la levure
|
WO2019042555A1
(fr)
|
2017-08-31 |
2019-03-07 |
Humabs Biomed Sa |
Anticorps multispécifiques se liant spécifiquement aux épitopes du virus zika et leurs utilisations
|
US11555199B2
(en)
|
2017-09-19 |
2023-01-17 |
Tropic Biosciences UK Limited |
Modifying the specificity of plant non-coding RNA molecules for silencing gene expression
|
CA3082365A1
(fr)
|
2017-11-09 |
2019-05-16 |
Pinteon Therapeutics Inc. |
Methodes et compositions pour la generation et l'utilisation d'anticorps tau phosphoryles specifiques a une conformation humanisee
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
WO2019106671A1
(fr)
|
2017-11-29 |
2019-06-06 |
Ramot At Tel-Aviv University Ltd. |
Procédés de traitement prophylactique ou thérapeutique de choc neurogénique
|
AR114936A1
(es)
|
2017-11-29 |
2020-11-11 |
Weedout Ltd |
Composiciones, kits y métodos para controlar la maleza del género amaranthus
|
EP3716993A1
(fr)
|
2017-12-03 |
2020-10-07 |
Yeda Research and Development Co. Ltd |
Traitement d'une maladie cardiaque ischémique
|
WO2019116376A1
(fr)
|
2017-12-17 |
2019-06-20 |
Yeda Research And Development Co. Ltd. |
Modulateurs du complexe signalosome cop9 (csn) et leurs utilisations
|
EP3731965A1
(fr)
|
2017-12-28 |
2020-11-04 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Procédé pour reproduire des rythmes circadiens sur une puce microfluidique
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
EP3749368A1
(fr)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Procédés d'identification et d'utilisation d'agents pour traiter des maladies associées à un dysfonctionnement de la barrière intestinale
|
WO2019155459A1
(fr)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs du protéasome 20s
|
US11571433B2
(en)
|
2018-02-23 |
2023-02-07 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
US20200408761A1
(en)
|
2018-02-28 |
2020-12-31 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
WO2019175869A1
(fr)
|
2018-03-12 |
2019-09-19 |
Yeda Research And Development Co. Ltd |
Traitement d'une maladie cardiaque
|
US11413336B2
(en)
|
2018-03-23 |
2022-08-16 |
Board Of Regents, The University Of Texas System |
Coccidioides antigens and methods of their use
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
EP3774047A1
(fr)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Utilisation de gradients de champ électrique pour commander l'expression génique
|
CN112236131A
(zh)
|
2018-03-29 |
2021-01-15 |
技术研究及发展基金有限公司 |
包含pten抑制剂的囊泡及其用途
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
WO2019220441A1
(fr)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions et méthodes de traitement du cancer résistant à un agent anticancéreux
|
WO2019229745A1
(fr)
|
2018-05-27 |
2019-12-05 |
Biolinerx Ltd. |
Agi-134 combinée à un inhibiteur de point de contrôle pour le traitement de tumeurs solides
|
CA3102975A1
(fr)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Procedes de regeneration et de transformation de cannabis
|
WO2019234754A1
(fr)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Constructions d'acide nucléique et procédés d'utilisation de celles-ci
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
EP3818529A2
(fr)
|
2018-07-08 |
2021-05-12 |
Yeda Research and Development Co. Ltd |
Évaluation spécifique à une personne de la sensibilité aux probiotiques
|
CN112543773B
(zh)
|
2018-07-11 |
2024-05-31 |
卡尔医学有限公司 |
SIRPα-4-1BBL变体融合蛋白及其使用方法
|
MX2021000264A
(es)
|
2018-07-11 |
2021-05-12 |
Immunity Pharma Ltd |
Compuestos peptidicos y usos terapeuticos de los mismos.
|
WO2020026241A1
(fr)
|
2018-07-31 |
2020-02-06 |
Collplant Ltd. |
Événement transgénique du tabac et procédés de détection et d'utilisation associés
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
US11548938B2
(en)
|
2018-08-21 |
2023-01-10 |
Quidel Corporation |
DbpA antibodies and uses thereof
|
CN113227359A
(zh)
|
2018-08-24 |
2021-08-06 |
耶达研究及发展有限公司 |
调节m2巨噬细胞极化的方法及其在治疗中的用途
|
CN113038951B
(zh)
|
2018-09-20 |
2024-04-30 |
耶达研究及发展有限公司 |
治疗肌萎缩侧索硬化的方法
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
SG11202106483WA
(en)
|
2018-12-19 |
2021-07-29 |
Humabs Biomed Sa |
Antibodies that neutralize hepatitis b virus and uses thereof
|
WO2020152686A1
(fr)
|
2019-01-23 |
2020-07-30 |
Yeda Research And Development Co. Ltd. |
Milieux de culture pour cellules souches pluripotentes
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
WO2020170239A1
(fr)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de génération d'organoïdes pour criblage à haut rendement de médicaments
|
JP2022521010A
(ja)
|
2019-02-21 |
2022-04-04 |
イッスム・リサーチ・デベロプメント・カムパニー・オブ・ザ・ヘブリュー・ユニバシティー・オブ・エルサレム リミテッド |
薬物誘導性腎毒性を減少させるための方法
|
WO2020178822A1
(fr)
|
2019-03-05 |
2020-09-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Oiseaux à édition de génome
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
CN113811547B
(zh)
|
2019-03-27 |
2024-06-25 |
国家医疗保健研究所 |
具有cd40激活特性的重组蛋白
|
WO2020194317A1
(fr)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Méthode de traitement de troubles liés aux lipides
|
US20220175807A1
(en)
|
2019-03-31 |
2022-06-09 |
Yeda Research And Development Co. Ltd. |
Anti-viral and anti-tumoral compounds
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
EP3969619A1
(fr)
|
2019-05-13 |
2022-03-23 |
Yeda Research and Development Co. Ltd |
Biomarqueurs de micro-adn acellulaire pour le pronostic et le diagnostic de maladies neurodégénératives
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
EP3973049A1
(fr)
|
2019-05-22 |
2022-03-30 |
Hadasit Medical Research Services and Development Ltd. |
Procédés de culture de cellules pluripotentes humaines
|
CA3140406A1
(fr)
|
2019-05-28 |
2020-12-03 |
Shanghaitech University |
Composition et methodes pour le traitement d'une dysplasie ectodermique 2, type clouston
|
AU2020291694A1
(en)
|
2019-06-12 |
2022-02-03 |
Hadasit Medical Research Services And Development Ltd. |
Methods of generating oligodendrocytes
|
US20220307008A1
(en)
|
2019-06-16 |
2022-09-29 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
WO2020261281A1
(fr)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Anticorps semaphorine 3a et leurs utilisations
|
KR20220042139A
(ko)
|
2019-07-04 |
2022-04-04 |
유코 아이엔씨. |
에피토프 제거된 알파 글리아딘 및 복강병 및 글루텐 민감성의 관리를 위한 이의 용도
|
US20220267409A1
(en)
|
2019-07-11 |
2022-08-25 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
EP3999851A4
(fr)
|
2019-07-16 |
2023-04-12 |
Ramot at Tel-Aviv University Ltd. |
Compositions et procédés pour le traitement de la tuberculose
|
WO2021019526A1
(fr)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Procédés de traitement et de diagnostic du cancer du poumon
|
US20220298522A1
(en)
|
2019-07-30 |
2022-09-22 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
WO2021028909A1
(fr)
|
2019-08-12 |
2021-02-18 |
Yeda Research And Development Co. Ltd. |
Test sanguin de réparation de l'adn pour prédire la réponse de patients atteints d'un cancer du poumon à une immunothérapie
|
WO2021033176A1
(fr)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Procédés mis à l'échelle de purification d'anticorps
|
EP4021463A1
(fr)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Traitement de la vaginose bactérienne
|
WO2021042000A1
(fr)
|
2019-08-29 |
2021-03-04 |
Vir Biotechnology, Inc. |
Compositions d'anticorps et méthodes pour traiter une infection par le virus de l'hépatite b
|
WO2021048852A1
(fr)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement du cancer du sein
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
WO2021084526A1
(fr)
|
2019-10-31 |
2021-05-06 |
Yeda Research And Development Co. Ltd. |
Bactéries autotrophes génétiquement modifiées pour la conversion de co2 en matériaux organiques
|
IL292879A
(en)
|
2019-11-11 |
2022-07-01 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanoantibodies for insect control and their uses
|
AU2019474716A1
(en)
|
2019-11-19 |
2022-07-07 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
KR20220131895A
(ko)
|
2019-11-21 |
2022-09-29 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
항-pd-1/il-15 면역사이토카인을 이용하여 pd-1을 표적으로 하는 신규한 면역요법
|
CN118465272A
(zh)
|
2019-12-04 |
2024-08-09 |
珠海泰诺麦博制药股份有限公司 |
抗人巨细胞病毒抗体及其用途
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
EP4077731A1
(fr)
|
2019-12-22 |
2022-10-26 |
Yeda Research and Development Co. Ltd |
Diagnostic de la démence frontotemporale
|
US20230048719A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
WO2021137230A1
(fr)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Procédés de culture de lymphocytes t et leurs utilisations
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
IL272074B1
(en)
|
2020-01-15 |
2024-08-01 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(fr)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Procédés d'analyse de membranes cellulaires
|
EP4096647A1
(fr)
|
2020-01-30 |
2022-12-07 |
Yeda Research and Development Co. Ltd |
Traitement d'une maladie hépatique aiguë à l'aide d'inhibiteurs de tlr-mik
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
WO2021152586A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
|
CN115335532A
(zh)
|
2020-02-09 |
2022-11-11 |
Nlc制药有限公司 |
Sars-cov-2快速检测测试
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
WO2021173674A1
(fr)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides ciblant des complexes mage-a3 peptide-mhc et leurs méthodes d'utilisation
|
US11376320B2
(en)
|
2020-03-05 |
2022-07-05 |
Iowa State University Research Foundation, Inc. |
Immunogenic and vaccine compositions against SARS-CoV-2
|
WO2021186431A1
(fr)
|
2020-03-16 |
2021-09-23 |
Yeda Research And Development Co. Ltd. |
Analogues peptidiques et leur utilisation dans le traitement de maladies, troubles ou états associés à une protéine p53 mutante
|
CN115348884B
(zh)
|
2020-03-29 |
2024-07-30 |
耶达研究及发展有限公司 |
用于治疗戈谢病的β-葡糖脑苷脂酶变体
|
IL296698A
(en)
|
2020-03-31 |
2022-11-01 |
Biomuse Ltd |
Bacteria for the prevention and treatment of smoking damage to the lungs
|
EP4133107A1
(fr)
|
2020-04-06 |
2023-02-15 |
Yeda Research and Development Co. Ltd |
Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
|
WO2021205459A1
(fr)
|
2020-04-07 |
2021-10-14 |
Ramot At Tel-Aviv University Ltd. |
Compositions contenant du cannabidiol et leurs utilisations
|
CN115666619A
(zh)
|
2020-04-13 |
2023-01-31 |
埃索普罗瑟医疗有限公司 |
用于抗病毒治疗的包含野生型p53蛋白的细胞衍生囊泡
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(fr)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagène utilisé comme outil d'administration d'agents antiviraux à base de métaux
|
WO2021228836A1
(fr)
|
2020-05-13 |
2021-11-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Protéines recombinantes ayant des propriétés d'activation de ox40
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
IL299201A
(en)
|
2020-06-24 |
2023-02-01 |
Vir Biotechnology Inc |
Transgenic hepatitis B virus neutralizing antibodies and their uses
|
WO2021260675A1
(fr)
|
2020-06-24 |
2021-12-30 |
Yeda Research And Development Co. Ltd. |
Agents pour sensibiliser des tumeurs solides à un traitement
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
WO2022038536A1
(fr)
|
2020-08-18 |
2022-02-24 |
International Rice Research Institute |
Procédés d'augmentation des taux de croisement de gramineae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
EP4217370A2
(fr)
|
2020-09-23 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Méthodes et compositions pour traiter des infections à coronavirus
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
EP4225902A1
(fr)
|
2020-10-05 |
2023-08-16 |
Protalix Ltd. |
Cellules végétales inactivées de type dicer
|
WO2022074656A1
(fr)
|
2020-10-07 |
2022-04-14 |
Protalix Ltd. |
Dnase à action prolongée
|
EP4228637A1
(fr)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Méthode de traitement des cancers myéloïdes
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
EP4240856A2
(fr)
|
2020-11-09 |
2023-09-13 |
1E Therapeutics, Ltd. |
Méthodes de traitement ou de prévention d'infections bactériennes faisant appel à une séquence catalytique
|
IL302707A
(en)
|
2020-11-26 |
2023-07-01 |
Ukko Inc |
A subunit of glutenin that has been modified and has a high molecular weight and its uses
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
IL304068A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
DNA enzymes against p21 messenger RNA
|
KR20230126725A
(ko)
|
2020-12-28 |
2023-08-30 |
1이 테라퓨틱스 엘티디. |
침묵화를 위한 P21 mRNA 표적 부위
|
JP2024502377A
(ja)
|
2021-01-10 |
2024-01-18 |
スーパーミート ザ エッセンス オブ ミート リミテッド |
培養肉産業用の多能性幹細胞凝集体及びそれから得られる微小組織
|
WO2022153286A1
(fr)
|
2021-01-14 |
2022-07-21 |
Yeda Research And Development Co. Ltd. |
Procédés de production de vitamine d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
WO2022164805A1
(fr)
|
2021-01-26 |
2022-08-04 |
Vir Biotechnology, Inc. |
Compositions et méthodes pour traiter une infection par le virus de l'hépatite b
|
JP2024506954A
(ja)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ワクチン作製用の遺伝子改変細菌
|
EP4294428A1
(fr)
|
2021-02-18 |
2023-12-27 |
Yeda Research and Development Co. Ltd |
Procédé de génération de vaccins
|
AU2022233857A1
(en)
|
2021-03-10 |
2023-09-14 |
Mabylon Ag |
Antibodies against tdp-43 and methods of using the same
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
WO2022208369A1
(fr)
|
2021-03-30 |
2022-10-06 |
Biomx Ltd. |
Bactériophage de pseudomonas et ses utilisations
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
CA3218291A1
(fr)
|
2021-05-12 |
2022-11-17 |
Lior Moshe ZELCBUCH |
Bacteriophage de staphylococcus et ses utilisations
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
WO2022259242A1
(fr)
|
2021-06-06 |
2022-12-15 |
Yeda Research And Development Co. Ltd. |
Traitement combiné du cancer
|
CN117836402A
(zh)
|
2021-06-13 |
2024-04-05 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
重编程人细胞的方法
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
EP4355502A1
(fr)
|
2021-06-16 |
2024-04-24 |
Seedx Technologies Inc. |
Procédés de tri de graines de matthiola
|
CA3223344A1
(fr)
|
2021-07-02 |
2023-01-05 |
Tropic Biosciences UK Limited |
Retardement ou prevention du brunissement de bananes
|
AU2022313138A1
(en)
|
2021-07-18 |
2024-02-29 |
Gamida-Cell Ltd. |
Therapeutic nk cell populations
|
WO2023002492A1
(fr)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Optimisation de codon d'acides nucléiques
|
EP4130028A1
(fr)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Complexe tcr modifié et leurs procédés d'utilisation
|
EP4380966A2
(fr)
|
2021-08-03 |
2024-06-12 |
Genicity Limited |
Complexe tcr modifié et ses procédés d'utilisation
|
AU2022325816A1
(en)
|
2021-08-10 |
2024-03-21 |
Gamida-Cell Ltd. |
Engineered nk cells, methods of their production and uses thereof
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
CA3240113A1
(fr)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Cellules progenitrices pulmonaires multipotentes pour la regeneration pulmonaire
|
WO2023144779A1
(fr)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Variants d'antigène de coronavirus
|
WO2023209708A1
(fr)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions pour modifier la signalisation de messager secondaire de l'adp-ribose cyclique
|
WO2023242155A1
(fr)
|
2022-06-14 |
2023-12-21 |
Janssen Vaccines & Prevention B.V. |
Compositions et procédés pour le diagnostic d'une infection par le vih
|